Neurology · Full case

Headache

NICE CKS 2023NG12ICHD-3
HA
Headache · Clinical Reasoning Framework v2
GP & SCA · NICE CKS (2023) · SAH · GCA · MOH · Migraine with aura + OCP · Cluster O2 · Topiramate teratogenicity
Thunderclap = 999Sudden-onset headache reaching peak severity in seconds — subarachnoid haemorrhage until proven otherwise; 999; CT head without contrast (sensitivity 98% within 6h); LP if CT negative; never reassure thunderclap headache in GP surgery
GCA: steroids NOWGiant cell arteritis: age ≥50 + new temporal headache + ESR/CRP elevated → prednisolone 40–60mg OD IMMEDIATELY; do NOT wait for temporal artery biopsy; anterior ischaemic optic neuropathy causes irreversible bilateral blindness within hours; ESR typically >50
MOH: >10–15 daysMedication overuse headache: simple analgesics >15 days/month OR triptans/opioids >10 days/month → rebound headache; one of the most common and treatable causes of chronic daily headache; GP must identify and support analgesic withdrawal
OCP + aura = UKMEC 4Migraine with aura + combined OCP = absolute contraindication (UKMEC Category 4); significantly increased ischaemic stroke risk; stop OCP immediately; switch to progestogen-only pill or non-hormonal contraception; always ask about aura in migraine patients on OCP
Cluster O2: 100%Cluster headache acute treatment: 100% oxygen 12–15 L/min via non-rebreather mask for 15–20 minutes; most effective and fastest treatment; GP prescribes home oxygen concentrator; OR subcutaneous sumatriptan 6mg; oral analgesics too slow for cluster
Topiramate ⚠ pregnancyTopiramate: highly effective migraine prophylaxis; TERATOGENIC (cleft palate, neural tube defects); absolutely contraindicated in pregnancy or if pregnancy possible without highly effective contraception; MHRA warning 2024; use propranolol or amitriptyline in women of childbearing potential
IIH: obese young womenIdiopathic intracranial hypertension: obese young women + pulsatile tinnitus + bilateral visual field loss + papilloedema + headache worse on coughing; CT/MRI; LP opening pressure >25 cmH2O; treatment: weight loss (most effective) + acetazolamide; monitor vision
Triptan + SSRI ⚠Triptans + SSRIs/SNRIs: potential serotonin syndrome risk (weak combination compared with other serotonergic drugs); monitor for symptoms if combination used; not absolute contraindication but counsel patient; avoid triptan + MAOIs (absolute contraindication)
📋 Clinical Stem — Headache
A 32-year-old teacher with 3-month history of worsening daily headaches, taking paracetamol and codeine most days, experiencing visual zigzag lines before headaches and on the combined oral contraceptive pill
Rachel Patel, 32, a secondary school English teacher, attends reporting worsening headaches over the past 3 months. The headaches have become almost daily. They are mainly bilateral frontal, throbbing, moderate-severe intensity, lasting 4–8 hours. She notices zigzag lines in her vision for approximately 20 minutes before most attacks, followed by the headache. She is taking paracetamol 1g and codeine 30mg on most days — "practically every day" — and the medication is increasingly less effective. She is on Microgynon (combined OCP) for contraception. She is a heavy social media user and spends considerable time on her phone in the evenings. She is stressed at work (new term, two difficult classes). She has been taking her OCP for 4 years without review for headache change. She has never been told she has migraine. Her mother has migraines.
This stem tests four critical clinical skills: identifying that Rachel has migraine with aura (visual zigzag = classic aura) and that her combined OCP is therefore absolutely contraindicated (UKMEC Category 4 — stroke risk); recognising medication overuse headache (daily paracetamol + codeine for 3 months = MOH threshold exceeded); supporting analgesic withdrawal as the primary therapeutic intervention; and explaining why "stronger painkillers" (her likely expectation) would make the situation worse, not better.
Scenario A — Thunderclap headache 45-year-old presenting to triage with sudden-onset "worst headache of their life" starting during sexual activity 2 hours ago; maximally severe within 30 seconds; still has headache; "GCS 15; no focal neurology. Action: 999 immediately; CT head without contrast (sensitivity 98% within 6 hours); LP if CT negative and clinical suspicion remains high (xanthochromia on spectrophotometry). Do NOT reassure and send home — SAH is fatal in 25% of cases on first presentation. The "sentinel headache" (mild sudden headache hours before major SAH) must not be dismissed.
Scenario B — Giant cell arteritis (GCA) 72-year-old with 3-week history of new temporal headache, scalp tenderness (cannot brush hair), jaw ache when eating, and right-sided blurred vision for 10 minutes this morning. Action: do NOT wait for ESR or biopsy result; start prednisolone 60mg OD immediately (vision symptoms → higher dose); refer to rheumatology or ophthalmology same day; arrange ESR + CRP (expected markedly elevated); temporal artery biopsy within 2 weeks; failure to treat = risk of irreversible bilateral anterior ischaemic optic neuropathy (permanent blindness).
Scenario C — Cluster headache 38-year-old male woken from sleep with excruciating right-sided periorbital pain, right eye watering and red, right nostril running, right eyelid drooping; pain maximal within 5 minutes; lasting 45 minutes; third attack this week. Classic cluster headache: autonomic features; male predominance; nocturnal attacks; episodic clusters. Management: 100% O2 12–15 L/min via non-rebreather mask × 15–20 minutes (prescribe home O2 concentrator); subcutaneous sumatriptan 6mg as alternative; prophylaxis: verapamil SR 240–480mg/day; refer neurology for cluster headache.
Scenario D — Idiopathic intracranial hypertension (IIH) 26-year-old obese woman (BMI 38) with 4-month progressive headache, pulsatile tinnitus ("whooshing sound in ears"), and transient visual grey-outs lasting seconds. Examination: papilloedema bilaterally on fundoscopy. IIH: CT/MRI brain (exclude secondary cause); LP with opening pressure measurement (target: >25 cmH2O with specific clinical features); management: weight loss (most effective — 6% weight loss = symptom resolution in many cases); acetazolamide; neurology referral; repeated LP if severe; optic nerve sheath fenestration if vision threatened.
Scenario E — Medication overuse headache (MOH) 48-year-old with 2-year history of "transformed migraine" — used to have episodic migraines once monthly; now has headaches every day; taking 8–10 ibuprofen tablets daily and a triptan most days; "nothing touches it." Classic MOH: analgesic use exceeding MOH thresholds for all drug classes. Management: withdrawal of all analgesics simultaneously (not tapering); bridging with prednisolone short-course (40mg × 5 days) or naproxen; expect worsening withdrawal headache for 7–10 days; add prophylaxis (amitriptyline or propranolol); warn that it gets worse before it gets better.
Key variables to adapt for Age (under 50: primary headaches predominant; over 50: GCA, intracranial pathology more likely with new headache); aura (visual zigzag/scotoma = classic migraine aura; motor or speech aura = hemiplegic migraine — specialist referral; aura + OCP = absolute contraindication); analgesic frequency (count days/month carefully to identify MOH); hormonal factors (menstrual migraine; OCP interaction; pregnancy — avoid topiramate, valproate); red flags throughout (SNOOP4 mnemonic); screen for mental health factors driving TTH (stress, depression, anxiety, sleep).
Steps:
1
Step 1
History Taking — Red Flags First · SNOOP4 · Aura · MOH Screen · OCP · ICE
collapse
The headache history has one overriding structural requirement: exclude dangerous secondary causes before characterising the primary headache. SNOOP4 (Systemic symptoms, Neurological signs, Onset sudden, Older age, Positional, Papilloedema, Progressive, Pregnancy/postpartum) screens for the life-threatening minority. For Rachel, two critical findings will emerge from the history: visual zigzag lines (migraine aura, making her OCP absolutely contraindicated) and daily analgesic use for 3 months (medication overuse headache). Neither of these is a red flag in the emergency sense — but both are clinically urgent in management terms.
🎓 SCA opener — ask about red flags first, then characterise the headache
"Before I ask about the headaches in detail — I want to ask you a few important questions first. Have you ever had a headache that came on extremely suddenly, like being hit on the head? Have you had any weakness, numbness, or speech problems with the headaches? Have you had a fever or a rash with them? And are you pregnant or could you be?"
Asking SNOOP4 red-flag questions before the detailed history demonstrates structured clinical thinking. In SCA: this approach scores Global Skills for structured data gathering and Tasks for demonstrating knowledge of secondary headache exclusion. It also prevents the consultation going down a detailed primary headache characterisation path before dangerous causes are excluded — which is the correct clinical sequence.
1A — Red flag exclusion (SNOOP4) then headache characterisation
QuestionWhy it mattersChanges what?
🟢 OPEN QUESTION"Tell me about the headaches — what they feel like, when they come on, and what has changed over the past 3 months." The open question establishes the narrative: onset, character, progression, and what Rachel has tried. Rachel's story reveals: 3 months of escalating headaches; daily occurrence; visual zigzag before most attacks (this is the aura — the most important clinical finding in this consultation); paracetamol + codeine daily (this is medication overuse). The open question also establishes the temporal relationship: what did the headaches feel like before the daily analgesia started? Were they episodic migraines that have transformed into daily headaches from overuse?In SCA: the candidate who asks "can you describe the headache?" is gathering data. The candidate who asks "tell me what has changed over the past 3 months — were the headaches different before?" is demonstrating causal clinical reasoning, which scores in both Tasks (identifying the MOH pattern) and Global Skills (structured consultation). Zigzag before headache = aura = migraine; daily analgesic use = MOH; frequency escalation = transformation patternAura + OCP = stop OCP immediately (UKMEC 4)
Onset speed — the thunderclap screen"Did any of these headaches come on very suddenly — like being hit on the back of the head — and reach maximum severity within seconds?"Thunderclap headache = subarachnoid haemorrhage until proven otherwise. The key feature is not the severity but the speed of onset: maximum severity within 60 seconds. SAH headache is often described as "the worst headache of my life" — but severity alone is insufficient; TTH can be severe. Speed of onset is the discriminating feature. Rachel's headaches build over time — not thunderclap. But this question must always be asked. Sentinel headache (mild sudden headache days to weeks before major SAH): 25–50% of SAH patients report a sentinel headache that was dismissed at a prior consultation. Missing a thunderclap headache in a GP consultation is one of the most serious diagnostic errors in general practice.Thunderclap confirmed: 999; CT head. Gradual onset: SAH less likely; proceed to characterisation.Thunderclap onset → 999 → CT head immediately
Aura — the zigzag question (critical for OCP safety)"Do you notice anything before the headache starts — visual changes like zigzag lines, flashes, or a blind spot? Numbness or tingling? Any speech or word-finding difficulty?"Rachel reports visual zigzag lines lasting approximately 20 minutes before most headaches. This is classic migraine aura — specifically a scintillating scotoma or fortification spectrum. Aura is the most important finding in this consultation because of the OCP interaction. Migraine with aura + combined OCP = UKMEC Category 4 (absolute contraindication). The mechanism: migraine aura involves cortical spreading depression → transient focal ischaemia; combined OCP increases prothrombotic state; together they significantly elevate ischaemic stroke risk. Types of aura: visual (most common — zigzag, flashes, scotoma, visual distortion); sensory (spreading tingling); motor (hemiplegic migraine — rare; SPECIALIST REFERRAL); speech/language. Duration: typically 20–60 minutes; visual aura typically 20–30 minutes. If the aura is exclusively motor or lasts >1 hour: MRI/neurology referral (atypical aura).Visual aura confirmed: MIGRAINE WITH AURA; OCP CONTRAINDICATED (UKMEC 4); stop OCP today; prescribe progestogen-only contraception or IUD. Hemiplegic aura or atypical aura: neurology referral. No aura: migraine without aura (OCP relative CI depending on other risk factors).Aura + OCP → stop OCP immediately; progesterone-only or IUD; UKMEC 4 absolute contraindication; stroke risk
Analgesic quantification — the MOH screen"How often are you taking the paracetamol and codeine? How many days in a typical week? How long have you been taking it this frequently?"Rachel takes paracetamol 1g + codeine 30mg "practically every day" for 3 months. This exceeds the MOH thresholds in all drug classes: simple analgesics (paracetamol, ibuprofen, aspirin): >15 days/month = MOH risk; codeine (opioid): >10 days/month = MOH risk; triptans: >10 days/month = MOH risk. MOH mechanism: chronic analgesic use causes central sensitisation and descending pain modulation dysregulation; the headache-free interval shortens; each dose of analgesic triggers less and less relief and shorter-lasting relief; the patient takes more analgesic to manage the increasing headache frequency, creating a vicious cycle. MOH is one of the most common and most treatable causes of chronic daily headache — and one of the most frequently missed. The treatment is withdrawal, not escalation. Rachel's expectation ("give me something stronger") is the opposite of the correct treatment.MOH confirmed: STOP codeine and paracetamol; begin withdrawal plan with bridge analgesic (naproxen 500mg BD for 2 weeks or prednisolone 40mg × 5 days); add prophylactic agent; warn about withdrawal headache worsening for 7–10 days. More codeine: CONTRAINDICATED — worsens MOH.Daily analgesics ≥3 months → MOH pattern; primary headache has transformedWithdrawal + bridge + prophylaxis; NOT escalation
Headache character — POUND mnemonic"Is the headache one-sided or both sides? Is it throbbing or pressing? How severe is it — does it stop you working? Does it last hours or days? Does it make you feel sick or sensitive to light or noise?"POUND mnemonic (Pulsating, One-day duration, Unilateral, Nausea, Disabling) — presence of ≥3 features has high specificity for migraine. Rachel: throbbing (pulsating) ✓; bilateral (actually most migraines are occasionally bilateral — bilateral alone does not exclude migraine); disabling (cannot function) ✓; 4–8 hours ✓; nausea/photophobia ✓. Combined with visual aura, this is confidently migraine with aura. Tension-type headache: bilateral, pressing/tightening (band-like), NOT throbbing, NOT worsened by activity, mild-moderate only, no nausea/vomiting, no photophobia. Cluster: periorbital/temporal, UNILATERAL, SEVERE, autonomic features (lacrimation, rhinorrhoea, ptosis), 15–180 minutes, agitated patient (cannot lie still — contrasts with migraine where patient lies still).Pulsating + unilateral + nausea + photophobia + disabling + aura: migraine with aura confirmed. Pressing/band-like: TTH. Severe periorbital + autonomic: cluster headache.Migraine with aura: OCP UKMEC 4; triptan-based treatment; consider prophylaxis. TTH: lifestyle; amitriptyline prophylaxis if chronic. Cluster: O2 + sumatriptan SC
Triggers and hormonal pattern"Have you noticed what brings the headaches on? Are they worse at certain times of the month? Does sleep, stress, or your period seem to trigger them?"Menstrual migraine: migraine occurring consistently within the window of 2 days before to 3 days after menstruation start; associated with oestrogen withdrawal. Management: if consistent, trial frovatriptan (longer-acting triptan) or naratriptan as mini-prophylaxis from day -2 to +3; or combined OCP without pill-free week (but NOT if migraine with aura). Common migraine triggers: stress (most common); sleep changes (oversleeping or sleep deprivation); alcohol (especially red wine and beer); skipping meals (hypoglycaemia); bright lights; hormonal changes; dehydration; tyramine-rich foods (cheese, cured meats). Caffeine withdrawal: important and under-recognised — heavy coffee drinker who skips morning coffee gets a caffeine withdrawal headache.Menstrual pattern: frovatriptan mini-prophylaxis or continuous OCP (only if migraine WITHOUT aura). Caffeine: reduction strategy. Stress: CBT, relaxation, sleep hygiene. Dietary triggers: food diary.Menstrual migraine: frovatriptan mini-prophylaxis; continuous pill (migraine WITHOUT aura only)
Associated symptoms — neurological screen"Have you had any weakness, numbness, vision changes lasting more than an hour, difficulty speaking or finding words, or episodes of confusion with the headaches?"Persistent (>1 hour) or progressive neurological symptoms with headache are red flags for secondary causes. Transient focal neurology lasting <1 hour in context of migrainous aura: typical for migraine (aura); still requires documentation. Symptoms requiring urgent investigation: new focal neurology persisting after headache resolves; progressive neurological deficit; cognitive decline; personality change; seizures. Hemiplegic migraine: motor aura (unilateral weakness); rare; can mimic TIA; requires MRI and specialist review; do NOT prescribe triptans (relatively contraindicated in hemiplegic migraine); do NOT start combined OCP. CARASIL and CADASIL: hereditary cerebrovascular diseases presenting with migraine, stroke, cognitive decline — suspect if strong family history.Persistent focal neurology: MRI brain + urgent neurology. Hemiplegic aura: neurology referral; MRI; no triptans; no OCP. Typical visual/sensory aura <1 hour: migraine with aura; OCP UKMEC 4.Persistent neurology: MRI urgently; hemiplegic aura: neurology
1B — Red flags (SNOOP4)
🚨

SNOOP4 — Secondary Headache Red Flags

Red flagLikely causeAction
Sudden onset — thunderclap headache (maximal in seconds)Subarachnoid haemorrhage (SAH): ruptured intracranial aneurysm. Thunderclap without meningism can also be: reversible cerebral vasoconstriction syndrome (RCVS — recurrent thunderclap; associated with vasoactive drugs, postpartum); cerebral venous sinus thrombosis; hypertensive emergency. Key feature: speed not severity. Maximum severity within 60 seconds = thunderclap regardless of absolute severity.999; CT head without contrast (98% sensitive within 6h); LP if CT negative (xanthochromia on spectrophotometry)
New headache in age ≥50 with temporal scalp tenderness, jaw claudication, or visual symptomsGiant cell arteritis (GCA): granulomatous vasculitis of medium-large vessels. ESR typically >50 (often >100); CRP elevated. Risk: anterior ischaemic optic neuropathy → bilateral irreversible blindness within hours. Jaw claudication (jaw ache when chewing — ischaemia of masseter) and scalp tenderness (inability to brush hair) are highly specific for GCA. Visual symptoms (amaurosis fugax, diplopia): immediate high-dose steroids.Prednisolone 40–60mg OD immediately (visual symptoms: 60mg); ESR + CRP; same-day ophthalmology if visual loss; temporal artery biopsy within 2 weeks
Headache + fever + neck stiffness + photophobia ± non-blanching rashBacterial meningitis (Neisseria meningitidis, Streptococcus pneumoniae) or viral encephalitis. Meningococcal septicaemia: non-blanching petechial/purpuric rash = septic emboli — most dangerous. Kernig's sign (inability to extend knee with hip flexed); Brudzinski's sign (neck flexion causes knee flexion). Neck stiffness may be absent in early disease or immunocompromised.999; IM/IV benzylpenicillin if meningococcal rash (do NOT delay transfer); IV dexamethasone; LP after CT if stable; blood cultures; PCR
Headache worse in the morning, on bending, coughing, or Valsalva; associated with vomiting, progressive visual change, or new focal neurologyRaised intracranial pressure: brain tumour (primary or metastatic), subdural haematoma (chronic — especially elderly on anticoagulants; history of minor head injury weeks prior), hydrocephalus, cerebral abscess. Idiopathic intracranial hypertension (IIH): obese young women; pulsatile tinnitus; papilloedema. Subdural haematoma: fluctuating conscious level, hemiparesis; anticoagulant/fall history.CT head (MRI if CT negative); urgent neurology/neurosurgery; fundoscopy (papilloedema); reduce anticoagulation if subdural suspected
Headache in pregnancy or postpartum with hypertension or visual changesPre-eclampsia/eclampsia: hypertension + proteinuria + headache + visual disturbance in pregnancy or up to 6 weeks postpartum. Cerebral venous sinus thrombosis (CVST): progressive headache in late pregnancy or postpartum; papilloedema; seizures; focal neurology; MRI + MRV. Postpartum headache + hypertension: treat as pre-eclampsia until proven otherwise.Pre-eclampsia: IV labetalol/hydralazine; magnesium sulphate (eclampsia prophylaxis); 999. CVST: anticoagulation; MRI + MRV; neurology.
New headache in patient with known malignancy or HIVCerebral metastasis: most commonly from breast, lung, renal, melanoma. Raised ICP, seizures, focal neurology. Leptomeningeal carcinomatosis: headache + cranial nerve palsies + radiculopathy. Opportunistic infections in HIV: cryptococcal meningitis (India ink or cryptococcal antigen); toxoplasmosis (ring-enhancing lesions). Progressive multifocal leukoencephalopathy (PML): JC virus in low CD4 count.CT/MRI with contrast; urgent neurology/oncology; LP if safe; HIV test if unknown status and suspected opportunistic infection
🛡️

Safeguarding Considerations in Headache

🏠 Domestic Abuse — Head Trauma
  • Chronic headache in a patient with a history of domestic abuse: consider chronic traumatic injury (subdural haematoma; post-concussion syndrome; cervicogenic headache from neck injury)
  • Ask about headache onset in relation to any injury; subdural haematoma may present weeks after even a minor head injury in anticoagulated patients
  • Always screen for domestic abuse in women with unexplained chronic pain syndromes including chronic daily headache
  • Safe enquiry: "sometimes people get headaches from falls or injuries — has anything like that happened to you?"
💊 Medication Misuse and Dependence
  • Codeine: opioid; dependence risk; Rachel is taking codeine 30mg daily — assess for dependence (taking to avoid withdrawal symptoms vs pain relief)
  • Codeine is available OTC in low doses; patients may be obtaining from multiple pharmacies
  • Withdrawal of codeine must be supported — abrupt cessation in dependent patients can cause significant symptoms
  • FRANK (0300 123 6600) and local drug and alcohol services for codeine dependence support
🧠 Mental Health and Chronic Pain
  • Chronic daily headache and MOH: high comorbidity with depression (40–50%) and anxiety; bidirectional relationship
  • PHQ-9 and GAD-7 at every chronic headache consultation
  • Catastrophising and pain hypervigilance amplify headache disability; CBT-based approaches are evidence-based
  • Sleep disruption from headache → depression → more headache → vicious cycle; sleep hygiene is a therapeutic intervention
🤰 Headache in Reproductive-Age Women
  • Rachel is 32 and on the OCP: migraine with aura + OCP = absolute contraindication — act today
  • Topiramate and sodium valproate: highly teratogenic; pregnancy test and highly effective contraception mandatory before prescribing in women of childbearing potential
  • Migraine commonly worsens in first trimester; may improve in second/third; paracetamol is safest acute analgesic in pregnancy
  • Triptans in pregnancy: limited safety data; generally avoided; sumatriptan has most data; not absolutely contraindicated but specialist input preferred
Rachel's codeine use: 3 months of daily codeine 30mg meets criteria for MOH and potentially for opioid dependence. Withdrawal must be planned and supported — not abrupt. Assess dependency symptoms before withdrawal plan. Brief CAGE screen for dependence (Cutting down; Annoyed; Guilty; Eye-opener). If dependence suspected: GP addiction support or community drug and alcohol service. Document the withdrawal plan and review at 2 weeks.
1C — PMH · Drug history
🧬 PMH · FH — relevant to headache diagnosis
FactorWhy it mattersImpact
Family history of migraineMigraine has strong familial aggregation — first-degree relative with migraine increases risk approximately 3-fold. Rachel's mother has migraines. FH of migraine supports the diagnosis (but does not confirm it). FH of hemiplegic migraine: suggests CACNA1A or other familial hemiplegic migraine gene — genetic testing and specialist review. FH of early stroke: relevant to OCP risk assessment.Positive FH: supports migraine diagnosis; strengthens confidence in prophylaxis decision. FH of early stroke: OCP risk discussion more urgent.
Previous migraine diagnosisHas Rachel ever been told she has migraine? Has she ever been prescribed a triptan? Understanding prior diagnostic and therapeutic history prevents duplication and establishes the timeline of disease evolution. If previously on triptan: which one? Did it work? At what dose? Triptan failure could indicate underdosing, wrong formulation (oral vs nasal vs SC), or MOH making triptans less effective.Prior triptan: assess effectiveness; if failure, check timing, dose, formulation; consider switching triptan class or route. Triptan overuse (>10 days/month): MOH.
Hypertension and cardiovascular riskHypertension + migraine with aura: very important for OCP decision (OCP in hypertension + migraine with aura = multiple stroke risk factors). Also relevant for sumatriptan prescribing: triptans relatively contraindicated in uncontrolled hypertension, ischaemic heart disease, cerebrovascular disease (vasoconstrictive mechanism). Propranolol for migraine prophylaxis is also an antihypertensive — dual benefit if hypertensive.Hypertension + migraine with aura: OCP absolutely contraindicated; BP must be controlled before triptan; propranolol migraine prophylaxis also treats BP. Avoid triptans if severe uncontrolled hypertension.
Depression / anxietyHigh comorbidity with chronic headache. Depression medications: amitriptyline (tricyclic) has dual role as antidepressant and migraine prophylactic — ideal choice when both are present. SSRIs: antidepressant benefit; modest headache benefit; serotonin syndrome risk with triptans (caution, not absolute contraindication). Venlafaxine: SNRI; evidence for migraine prophylaxis; useful if depression present.Depression + migraine: amitriptyline or venlafaxine — dual benefit. SSRI + triptan: counsel on serotonin syndrome symptoms (rare at normal doses); monitor. PHQ-9 at every chronic headache review.
💊 Drug history — triggers and interactions
Drug / factorWhy it mattersImpact
Combined OCP (Microgynon)Critical interaction: migraine with aura + combined OCP = UKMEC Category 4 (absolute contraindication). UKMEC Category 4: condition represents unacceptable health risk if method used. Stop OCP today. Explain the mechanism: cortical spreading depression in aura + prothrombotic OCP = significantly elevated ischaemic stroke risk. Alternative contraception: progestogen-only pill (Cerazette/desogestrel 75mcg); hormonal IUS (Mirena); non-hormonal IUS (copper); barrier methods. The UKMEC 4 designation means the risk clearly outweighs the benefit — this is not a discussion about risk-benefit, it is a clear clinical instruction.Stop OCP today. Prescribe progestogen-only pill (Cerazette 75mcg OD) or offer IUS/copper IUD as alternatives. Document UKMEC 4 discussion in notes. Ensure Rachel understands the stroke risk and agrees to stop OCP.
Codeine 30mg dailyOpioid analgesic: MOH risk at >10 days/month; Rachel is taking daily = confirmed MOH. Additional concern: dependence risk. Codeine is metabolised by CYP2D6 to morphine; ultra-rapid metabolisers (approximately 6% of Caucasian population) convert more codeine to morphine and are at higher overdose risk. Codeine should NOT be used for headache (rebound headache risk; dependence; no evidence for headache beyond acute pain). Withdrawal: gradual taper or supervised abrupt withdrawal; predict 7–10 days of worsening headache.Stop codeine — cannot continue; causes MOH; dependence risk. Plan withdrawal: naproxen bridge or prednisolone 40mg × 5 days. Warn: headache will worsen for 7–10 days before improving. Review at 2 weeks.
NSAIDs (ibuprofen)If Rachel is also taking ibuprofen: also a MOH risk at >15 days/month. NSAIDs in migraine: helpful acutely at correct doses (ibuprofen 400mg; aspirin 900mg with metoclopramide 10mg — first-line acute migraine treatment). But daily NSAID use causes MOH and GI toxicity. Also: NSAIDs can trigger headache independently in susceptible individuals (paradoxical effect). All analgesics must be stopped as part of MOH withdrawal.All analgesics (paracetamol, NSAIDs, opioids) must stop simultaneously during MOH withdrawal; not one at a time. Bridge with naproxen 500mg BD × 2 weeks or prednisolone short-course.
Screen: antihypertensives, nitrates, hormones, OTC decongestantsDrug-induced headache: nitrates (GTN, isosorbide) — classic cause of pounding headache; phosphodiesterase inhibitors (sildenafil); calcium channel blockers (especially nifedipine); antihypertensives; hormone replacement therapy; OTC decongestants (rebound headache); ergotamines. Any medication started around the time headaches began or worsened warrants consideration as a causative factor.If drug-induced: stop or switch the offending agent; headache should resolve within weeks. Document medication review in notes.
1D — ICE
💭 Ideas
"What have you been thinking about why the headaches have got so much worse? Have you been worried about a specific cause?"
Rachel has been having headaches and taking increasing amounts of medication for 3 months. She may believe she has a brain tumour (common health anxiety in chronic headache). She may believe she just needs stronger painkillers. She may not know that daily analgesics can cause rebound headache — this is genuinely counterintuitive and needs specific explanation. Understanding her current illness model allows the GP to target the education. The "headaches getting worse despite more medication" narrative needs a specific explanation: it is the medication causing the escalation, not the progression of the underlying disease.
😟 Concerns
"You've been living with these headaches for months — what is your biggest worry about what might be causing them?"
Rachel's underlying concern may be a brain tumour — this is the most common health anxiety associated with chronic headache. It should be addressed specifically and honestly: "The fact that the headaches are daily, both-sided, and have been happening for 3 months without other neurological symptoms makes a tumour very unlikely — tumour headaches tend to be progressive, worse in the morning, associated with vomiting, and often accompanied by other symptoms. I don't think we need a scan urgently, and I want to explain why." This direct address of the unexpressed concern is far more therapeutic than a generic "I'm sure it's fine."
🎯 Expectations
"What were you hoping I might be able to do today — stronger medication, a scan, or something else?"
Rachel almost certainly wants stronger pain relief. The therapeutic challenge is to explain why stronger analgesia is contraindicated and will make the situation worse — while validating that she is in pain and that the GP is taking it seriously. "I'm not going to give you stronger painkillers — not because I don't believe you are in pain, but because I am going to explain why the pain relief itself is part of what's driving the daily headaches. There is a way out of this cycle, but it involves stopping the analgesics, not increasing them." This reframe is the central task of this consultation.
1E — Psychosocial context
🫂 The MOH trap — analgesics as the solution and the problem

Rachel is in a pain management trap. She is in genuine pain from migraine. She takes analgesics to relieve the pain. The analgesics provide relief — but their daily use creates a neurobiological cycle of rebound headache. She takes more analgesics to relieve the rebound, which worsens the rebound. After 3 months, she is having daily headaches and the medication is working less and less well. The counterintuitive message — "the treatment is making you worse; the way to get better is to stop taking the medication" — is psychologically difficult for someone who is in genuine pain. The GP's task is to explain this cycle with empathy, validate that the pain is real, and support the difficult process of withdrawal.

💊 The Rebound Trap

Rachel's escalating daily headaches despite increasing analgesia is a classic MOH presentation. The mechanism is counterintuitive: analgesics used more than 10–15 days per month downregulate endogenous pain modulation pathways and sensitise central pain processing, making the headache threshold lower and lower. Each dose of analgesic provides relief but the baseline pain intensity increases. This is not tolerance in the pharmacological sense — it is a neurobiological remodelling effect specific to MOH.

"The medication is not failing because your headaches are getting worse independently — the daily pain relief is actually the main thing driving the daily headaches. It sounds strange because you're in real pain, but stopping the painkillers — with support — is the treatment that gives most people their lives back."
🏫 Occupational Stress as Trigger

Rachel is a teacher in a stressful term. Stress is the most common migraine trigger and a significant perpetuating factor in chronic daily headache. The relationship between stress and headache is bidirectional: stress triggers headaches; headaches create stress (workplace absences, concentration impairment, social withdrawal). Sleep disruption from headache and stress compounds both. Addressing stress is both a headache management strategy and an occupational health concern.

"Work stress is one of the most common migraine triggers. It's not all in your head — there's a real biological pathway between stress and headache. Part of the treatment plan is looking at sleep hygiene, relaxation, and whether there is support at school. Is there anything at work that we could address?"
🚺 OCP and Contraception Identity

Stopping the OCP is a significant practical and emotional event. Rachel has been on Microgynon for 4 years. The OCP may be integral to her contraceptive planning, her relationship, and her identity. The GP must explain clearly why the OCP must stop (UKMEC 4 — not a risk-benefit discussion), offer concrete alternatives (progestogen-only pill — similar mechanism but without the oestrogen that drives the risk), and acknowledge that this is an additional change on top of analgesic withdrawal. The progestogen-only pill (desogestrel, Cerazette) does not worsen migraine and is not associated with stroke risk.

"I know stopping the pill is an additional thing to deal with. I want to be clear why: the zigzag before the headache is what we call an aura, and with aura the combined pill carries a significant stroke risk. But the progestogen-only pill is just as effective for contraception and doesn't carry that risk. I can prescribe that today."
📱 Screen Time and Sleep

Rachel's heavy social media use and evening phone use likely contributes to poor sleep quality (blue light; cognitive arousal; delayed sleep onset). Sleep changes — particularly sleep deprivation or irregular sleep patterns — are among the most potent migraine triggers. Sleep disruption also perpetuates MOH by impairing endogenous pain modulation. Addressing sleep hygiene is both a migraine management strategy and an important wellbeing intervention. The message: consistent sleep-wake times; screens off 60 minutes before sleep; sleep at the same time every day (including weekends).

"The phone in the evenings is probably affecting your sleep more than you realise, and poor sleep is one of the strongest migraine triggers. Consistent sleep — same time every night — is actually one of the most effective migraine prevention strategies. It sounds simple, but the evidence is strong."
🧠 Health Anxiety About Headache

Chronic headache frequently coexists with health anxiety, particularly around brain tumour fears. Addressing this directly — not dismissing it but engaging it specifically — reduces the anxious amplification of pain perception. "I want to address the worry about something serious" — naming the fear specifically and explaining why the clinical picture does not fit tumour changes the patient's illness framework and reduces catastrophising, which is a significant driver of headache-related disability.

"I want to address the worry about something serious going on. The pattern of your headaches — daily, both sides, years of similar headaches in your mother, the visual symptoms before — this is a very recognisable picture of migraine complicated by medication overuse. This is not a brain tumour pattern. I don't think we need a scan right now, and I want to explain why."
🤝 Withdrawal as Empowerment

The MOH withdrawal conversation requires framing the stopping of medication as an active treatment, not a denial of care. Rachel is in pain and wants relief. Being told to stop all painkillers feels like abandonment. The reframe: "stopping the medication IS the treatment; in 3–4 weeks, most people notice a dramatic improvement in headache frequency; the few weeks of worsening are the price of getting your life back." Peer testimony (most patients find this transformative) and a clear review plan (2 weeks) supports engagement with the withdrawal process.

"I know this is not what you came in hoping for. You came in hoping for stronger pain relief — and I'm going to ask you to stop the pain relief you are taking. That is a hard ask. But most people who go through this — and the first 10 days are genuinely worse — say that 4 weeks later they cannot believe how much better they feel. This is a treatment. I want to see you in 2 weeks."
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases that score
"I noticed you mentioned zigzag shapes in your vision before the headache — that's actually really important. That's what we call a migraine aura. The reason it matters so much is that the combined pill and migraine with aura together carry a significant stroke risk. I need to stop the combined pill today and give you an alternative."
"I want to ask you something important before I say anything about stronger medication: how many days in a typical week are you taking the paracetamol and codeine? [Daily] And how long has it been that frequent? [3 months] I need to explain why that is actually part of what's causing the daily headaches."
"The medication has stopped working because taking it every day actually lowers your pain threshold over time — it's called medication overuse headache. The treatment is to stop all the analgesics, with my support. It gets worse for about 10 days, then dramatically better. I know that's not what you came in hoping for."
Deductions
  • Not asking about aura — the MOST important single question in this consultation; migraine aura determines the OCP decision
  • Not asking about analgesic frequency — MOH is the primary driver of daily headaches; must be quantified
  • Prescribing stronger analgesics (codeine escalation or tramadol) — worsens MOH; serious clinical error
  • Continuing the combined OCP without discussing UKMEC 4 — stroke risk; absolute contraindication
🔴 Red
Aura not asked; OCP continued without discussion; stronger analgesic prescribed; MOH not identified; thunderclap not screened; codeine escalation offered
🟠 Amber
Aura asked; OCP not addressed despite aura; MOH identified but withdrawal plan vague; red flags partially screened; ICE partial; health anxiety not addressed
🟢 Green
SNOOP4 red flags excluded; aura identified → OCP stopped + progestogen-only prescribed; MOH identified and explained mechanistically; withdrawal plan with bridge; ICE all three; health anxiety addressed; no stronger analgesics; prophylaxis discussed; 2-week review
2
Step 2
Triage — SAH Emergency · GCA Urgency · Primary Headache Routine
collapse
Headache triage uses two sequential questions: Is this a red flag headache that requires emergency action? If not, which primary headache type is this, and what is the urgency of management? The vast majority of headaches presenting to GP are primary (migraine, TTH, cluster) and are managed in the community. The minority that are secondary require immediate action. Getting the triage wrong in either direction — overtreating benign headaches with unnecessary investigation, or undertreating a SAH — is the central clinical challenge.
🔴 Emergency

999 / Same-Day Hospital

Act before completing history
  • Thunderclap headache — sudden onset maximal in seconds999; CT head without contrast; LP if CT negative; SAH until proven otherwise regardless of severity
  • Headache + fever + non-blanching rashMeningococcal meningitis; 999; IM benzylpenicillin before transfer if rash present; do not delay transfer for LP
  • New headache + focal neurology + impaired consciousness999; CT head; raised ICP, intracerebral haemorrhage, or encephalitis
  • Headache + BP >180/120 + papilloedemaMalignant hypertension; IV antihypertensives in hospital; do NOT lower BP too fast (risk of watershed infarct)
  • Headache in pregnancy with hypertension + proteinuriaPre-eclampsia/eclampsia; 999; IV labetalol/MgSO4; obstetric emergency
🟠 Urgent (Same-Day)

Immediate Specialist Assessment

Today
  • GCA with visual symptoms — age ≥50Prednisolone 60mg immediately; same-day ophthalmology; do NOT wait for ESR/biopsy
  • New severe headache in immunocompromised (HIV, cancer, transplant)CT head + LP; cryptococcal meningitis; toxoplasmosis; same-day assessment
  • First-ever "worst headache of life" — even if not thunderclapCT head; further assessment in A&E; do not reassure without investigation
🟢 Routine

GP Management

Primary headache — community
  • Migraine with aura — RachelStop OCP today; prescribe progestogen-only; MOH withdrawal plan; triptan for acute; prophylaxis if frequent; review 2–4 weeks
  • Tension-type headacheLifestyle; paracetamol/ibuprofen acutely; amitriptyline if chronic (>15 days/month); stress management
  • Cluster headache — new diagnosisRoutine neurology referral; prescribe O2 concentrator; subcutaneous sumatriptan; verapamil prophylaxis
🎓 SCA Checkpoint — Step 2Tasks
Triage rationale for Rachel
"From what you've told me, the headaches are not coming on suddenly like a thunderclap, you haven't had a fever or a rash, and you haven't had any weakness or speech problems. That's reassuring — it means the dangerous causes are much less likely. What I am seeing is a pattern of migraine with aura that has been complicated by the daily pain relief, and we need to address both of those today."
Deductions
  • Not performing any red flag screen before treating as primary headache — even if the diagnosis appears clear, the thunderclap screen must be performed
3
Step 3
Examination — BP · Neurological · Fundoscopy · Neck
collapse
Neurological examination in headache is primarily to identify secondary causes — not to characterise primary headaches, which are diagnosed clinically from history. The most important examinations are blood pressure (malignant hypertension; OCP monitoring), fundoscopy (papilloedema — raised ICP), and a brief neurological screen (focal signs — SOL, stroke). In Rachel's case, the examination confirms: normal BP (expected; but important given OCP), no focal signs, no papilloedema.
ExaminationWhat to findFinding changes managementChanges?
Blood pressure — both armsBP in headache: malignant hypertension (BP >180/120 + papilloedema = hypertensive emergency; headache + papilloedema + end-organ damage). Also important in context of OCP use: OCP causes hypertension in 5% — BP monitoring is part of OCP review. Headache is NOT a reliable BP symptom — most hypertensive headache is actually from extremely high BP (>180 diastolic) not the modest elevation seen commonly. BP monitoring for Rachel: important before prescribing progestogen-only pill (normal BP expected but document) and before any triptan prescription (triptans relatively CI in uncontrolled hypertension).BP >180/120 + headache: malignant hypertension — same-day hospital. Elevated BP 140–180: treat hypertension alongside headache; check before triptan. Normal BP: triptan safe; OCP-related hypertension excluded.YES — malignant hypertension; triptan safety; OCP monitoring
Fundoscopy — bilateralPapilloedema: most reliable physical sign of raised intracranial pressure; bilateral disc swelling with blurred margins, venous engorgement, loss of venous pulsations. Bilateral papilloedema in a young obese woman = IIH until proven otherwise. Papilloedema + headache + any neurological sign: CT/MRI urgently. Note: fundoscopy is technically challenging in a well-lit room — ideally dilated; GP can use ophthalmoscope to screen. Also look for: focal arterial narrowing (GCA — if arteries seen); hypertensive retinopathy (AV nipping, cotton wool spots, flame haemorrhages).Papilloedema: CT/MRI brain urgently; neurology/ophthalmology; IIH vs mass lesion. Normal fundi: raised ICP much less likely (but not excluded). Hypertensive retinopathy: severe hypertension; treat BP urgently.YES — papilloedema changes urgent pathway to CT/MRI
Neurological examination — cranial nerves, limbs, gaitBrief targeted examination: cranial nerves (III, VI palsy = false localising sign of raised ICP; facial palsy; jaw weakness suggests GCA in temporal region); limbs (tone, power, reflexes — focal asymmetry suggests SOL or hemiplegic migraine); cerebellar (finger-nose test; gait — cerebellar posterior fossa lesion or basilar migraine); neck stiffness (meningism — passive neck flexion causes pain and resistance). Normal neurological examination in a patient with recurrent stereotyped headache: strongly supports primary headache; no urgent investigation indicated.Focal neurology: MRI brain + urgent neurology referral. Neck stiffness: meningism → CT head + LP (if not in emergency setting). Normal exam: supports primary headache diagnosis; no scan needed.YES — focal neurology changes triage to urgent pathway
Temporal arteries — palpation (if age ≥50)In any patient aged ≥50 with new-onset headache: palpate temporal arteries bilaterally. GCA signs: tender temporal artery on palpation; beaded, thickened, or nodular artery; reduced or absent pulsation. Scalp tenderness (hair-brushing pain). Jaw claudication cannot be assessed by examination but elicited in history. Fundoscopy: ischaemic optic neuropathy in GCA may show a pale swollen optic disc. Rachel: age 32 — temporal artery examination not required. But this examination is essential in any patient ≥50 with new headache.Tender thickened temporal artery in ≥50: GCA; start prednisolone immediately; same-day ophthalmology if visual symptoms. Normal temporal artery pulsation: GCA less likely but does not exclude (normal pulsation in 10–15% of GCA).YES (if ≥50) — tender artery → immediate steroids
🎓 SCA Checkpoint — Step 3Tasks
Examination rationale
"I want to check your blood pressure — especially as we are discussing your pill — and have a quick look at your eyes and check your nervous system. For most headaches, the examination is normal, but I want to be sure."
Deductions
  • Not checking BP before prescribing progestogen-only pill or triptan — standard clinical assessment; triptan relatively contraindicated in uncontrolled hypertension
4
Step 4
Investigations — When to Scan · ESR/CRP · Headache Diary
collapse
Most primary headaches do NOT require investigation. NICE guidance: neuroimaging is NOT routinely indicated for chronic headache with no red flags or atypical features. Rachel does not require a CT or MRI — and explaining this clearly, with reasons, is an important part of the consultation (addresses health anxiety while avoiding inappropriate scanning).
InvestigationWhen indicatedWhat it changes
CT head (without contrast) — for suspected SAHIndicated: thunderclap headache; sudden-onset worst headache of life; headache + altered consciousness; headache + focal neurology; suspected SAH. NOT indicated: chronic headache without red flags; migraine without new features; tension-type headache. CT sensitivity for SAH: ~98% within 6 hours of ictus; falls to ~93% at 24 hours; ~50% at 1 week. If CT negative but thunderclap: LP at 12 hours post-ictus (allows xanthochromia to develop — bilirubin detected by spectrophotometry, not naked eye). Xanthochromia on LP = SAH until proven otherwise. MRI: superior for posterior fossa, brainstem, vascular malformations, subdural haematoma — order when CT negative and secondary cause still suspected.SAH confirmed on CT: neurosurgery immediately; ICU; nimodipine. CT negative + thunderclap: LP at 12 hours. Xanthochromia on LP: SAH; neurosurgery. All clear: primary headache; reassure; manage accordingly.
MRI brain with and without contrast — for raised ICP / SOLMRI indications: progressive headache with papilloedema; headache + persistent focal neurology; headache + personality change or cognitive decline; headache + seizure; known malignancy with new headache; suspected CNS tumour or AVM; suspected IIH (showing enlarged optic nerve sheaths, empty sella, slit-like ventricles). Superior to CT for: posterior fossa; brain metastases (gadolinium enhancement); low-grade glioma; subdural collection. For most recurrent stereotyped primary headaches: NOT indicated. Explaining why a scan is NOT needed (and why normal scans in chronic headache are the expected result) is more therapeutic than ordering an unnecessary CT.MRI shows mass/SOL: neurosurgery or neuro-oncology urgently. IIH features: LP for opening pressure; weight management; acetazolamide; neurology. Normal MRI: strongly supports primary headache; significant patient reassurance value.
ESR + CRP — for suspected GCAIn any patient ≥50 with new temporal headache: ESR and CRP urgently. GCA: ESR typically >50 mm/hr (often >100); CRP markedly elevated. CAUTION: treatment with prednisolone reduces ESR and CRP rapidly — start steroids FIRST; then arrange bloods. Do not delay steroids waiting for ESR result. Normal ESR does not exclude GCA (10–20% of GCA have normal ESR). CRP is more sensitive than ESR in some cases. Temporal artery biopsy: gold standard but can be arranged after treatment starts; biopsy within 2 weeks of steroids is acceptable as histological changes persist.Elevated ESR/CRP: confirms inflammatory process; supports GCA; continue steroids + biopsy. Normal ESR: reduces but does not exclude GCA; if clinical picture is strong, treat anyway. Temporal artery biopsy: definitive histological confirmation but treatment should not wait.
Headache diary — for all primary headache patientsThe headache diary is the most important "investigation" for primary headache management. It quantifies: headache frequency (days/month); character of each attack (duration, severity, features); analgesic use (type, dose, frequency — identifies MOH pattern); triggers (hormonal, dietary, sleep, stress); response to treatment. The diary serves multiple functions: confirms diagnostic classification; identifies MOH; provides baseline for treatment response; demonstrates analgesic overuse to the patient (concrete numbers change behaviour more than verbal explanation). Headache diary apps: Migraine Buddy; Migraine Monitor; simple paper diary equally effective.Diary confirms MOH pattern (>15 days analgesic use): withdrawal plan becomes non-negotiable with evidence. Diary identifies clear triggers: targeted avoidance strategy. Diary shows <3 days/month attacks: acute treatment only; no prophylaxis needed. ≥4 days/month + disability: prophylaxis indication.
🎓 SCA Checkpoint — Step 4TasksRelating to Others
Explaining why no scan is needed
"I want to address the possibility you might be wondering about — a scan. The pattern of your headaches — years of a similar experience, your mother has the same, the visual zigzag before, no weakness or numbness, no fever — this is a very recognisable picture of migraine. The guidelines say we do not routinely scan for this type of headache. Scanning you would be very likely to give a normal result and not change the treatment. If there is any change in the headaches — new features, sudden onset, or weakness — I would absolutely reconsider."
Deductions
  • Scanning Rachel without clinical indication — unnecessary; does not change management; creates scan-dependent health anxiety behaviour
  • Not ordering ESR/CRP if GCA is suspected in any patient ≥50 — critical diagnostic test that must not be missed
5
Step 5
Diagnosis — Plain Language · Primary vs Secondary · ICHD-3 Criteria
collapse
Rachel has two co-existing diagnoses that must both be communicated: migraine with aura (the underlying primary headache disorder) and medication overuse headache (the iatrogenic escalation). Explaining these together requires care — acknowledging the pain is real, explaining the counterintuitive withdrawal treatment, and providing hope that improvement is achievable and expected.
🗣️ Explaining migraine and MOH in plain language

"You have two things going on that are connected. The first is migraine — a neurological condition where your brain generates pain that is often one-sided, throbbing, with nausea and sensitivity to light, and in your case preceded by those visual zigzag shapes which are what we call an aura. Migraine is a recognised, treatable condition — and the fact that your mother has it is typical. The second thing is what we call medication overuse headache. When you take pain relief more than about 10 to 15 days in a month — which you've been doing — your brain's pain-regulating system becomes overwhelmed, and instead of working properly to modulate pain, it starts generating more pain between doses. The more you take, the more often the headaches come, the more you need — it's a trap. The way out is to stop the pain relief, with my support, and add a preventive medication instead. The first 7 to 10 days will be harder — your headaches will likely worsen before they improve. But for most people, 3 to 4 weeks later the daily headaches are gone and they get back to episodic migraines they can manage properly."

💬 Addressing the "I just need stronger painkillers" expectation

"The paracetamol isn't working any more — I need something stronger."
"I completely understand why you feel that — the medication isn't giving relief and you're in pain every day. But I have to be honest with you: stronger painkillers would make the situation worse, not better. The daily headaches are being driven by taking pain relief every day. Adding codeine-based medication would deepen the rebound cycle. The treatment that actually works is stopping all the daily pain relief — which I know sounds counterintuitive when you're in pain — and adding a preventive medication instead."

"Could you do a brain scan just to rule things out?"
"I understand why you'd want that peace of mind. The pattern of your headaches — exactly matching migraine, with the visual aura, in the same way your mother experiences them — doesn't raise any features that would make me worried about something structural. If I were worried, I'd scan you today. The guidelines say we shouldn't scan routinely for this pattern because it would be very likely to give us a normal result and not change the treatment. If anything changes — sudden onset, new weakness, or the headaches feel completely different — you should call us."

Primary Headaches — GP manages
Majority of headaches in GP
Migraine with aura (Rachel): Visual/sensory aura preceding headache; POUND features; photophobia; nausea. ICHD-3: ≥5 attacks; 4–72h; unilateral; pulsating; moderate-severe; nausea/vomiting OR photophobia + phonophobia. Aura: ≥1 fully reversible symptom, gradual spread over ≥5 min, lasts 5–60 min.
Tension-type headache: Band-like, bilateral, pressing, mild-moderate, no nausea, not worsened by activity. Most common primary headache worldwide.
Cluster headache: Severe unilateral periorbital; autonomic features; male predominance; episodic clusters; agitated patient.
MOH and Drug-Induced — Treatable
Common; frequently missed

Medication Overuse Headache (Rachel)

Daily analgesics >10–15 days/month. MOH transforms episodic migraine into chronic daily headache. Withdrawal + prophylaxis = cure for most patients.

Drug-induced headache

Nitrates, PDE5 inhibitors, OCP (withdrawal in pill-free week), caffeine withdrawal, decongestants, antihypertensives. Review medication timeline.

Secondary — Must Not Miss
Life-threatening minority

SAH

Thunderclap; worst headache of life; sentinel headache; 999; CT; LP if negative.

GCA

Age ≥50; temporal headache; jaw claudication; visual symptoms; steroids immediately; do not wait for biopsy.

Raised ICP / IIH

Morning headache; papilloedema; progressive; obese young women; CT/MRI; LP opening pressure.

📊 Headache Type Classification — ICHD-3 Diagnostic Criteria (simplified)
Headache typeKey features (ICHD-3)Distinguishing fromGP management
Migraine without aura≥5 attacks; 4–72h; unilateral; pulsating; moderate-severe; nausea/vomiting and/or photophobia + phonophobia; worsened by routine activityTTH: not pulsating; not unilateral; not worsened by activity; no nauseaAcute: aspirin 900mg + metoclopramide 10mg OR triptan if severe; Prophylaxis if ≥4/month: propranolol, amitriptyline, topiramate
Migraine with aura (Rachel)As above PLUS aura: ≥1 fully reversible visual, sensory, speech, or motor symptom; gradual spread; 5–60 minutes; aura precedes headache within 60 minTIA: aura spreads gradually (positive phenomena); TIA has negative phenomena; TIA in older patients; aura in known migraine patient = expected; new aura in ≥50: investigateAs above PLUS stop combined OCP (UKMEC 4 — absolute CI); progestogen-only contraception; migraine prophylaxis if frequent
Tension-type headache (TTH)≥10 attacks; 30 min–7 days; bilateral; pressing/tightening (not pulsating); mild-moderate; no nausea/vomiting (mild nausea possible in chronic TTH); NOT worsened by routine physical activity; no photophobia + phonophobia simultaneouslyMigraine: TTH pressing not throbbing; bilateral not unilateral; activity does not worsen; no nausea/vomiting; no auraAcute: paracetamol 1g or ibuprofen 400mg; Prophylaxis if chronic (≥15 days/month): amitriptyline 10–75mg OD (best evidence); relaxation therapy; biofeedback; address stress
Cluster headacheExcruciating unilateral orbital/periorbital pain; 15–180 min; ≥1 ipsilateral autonomic symptom (lacrimation, rhinorrhoea, ptosis, miosis, forehead sweating, conjunctival injection); agitated (cannot lie still — contrasts with migraine); 1–8 attacks/day; episodic clusters weeks to monthsMigraine: cluster periorbital not generalised; autonomic features; agitated not still; shorter duration; male predominanceAcute: 100% O2 12–15 L/min NRB mask 15–20 min OR subcutaneous sumatriptan 6mg; Prophylaxis: verapamil SR 240–480mg/day; refer neurology
MOH (Rachel)Headache ≥15 days/month for >3 months; regular overuse of: simple analgesics ≥15 days/month, opioids/triptans/ergotamines ≥10 days/month; developed during medication overuse; markedly improved after withdrawalUnderlying primary headache still present but transformed by MOH; diagnosis confirmed retrospectively after successful withdrawal (headache pattern reverts to episodic)Withdrawal of ALL analgesics simultaneously; bridge: naproxen 500mg BD × 2 weeks or prednisolone 40mg × 5 days; prophylaxis (amitriptyline or propranolol); review at 2 weeks; warn about withdrawal worsening
🎓 SCA Checkpoint — Step 5TasksRelating to Others
Diagnosis explanation
"You have migraine — a neurological condition, not "just headaches," that involves the way your brain processes pain signals. In your case, you also have the visual zigzag beforehand, which is the aura. Migraine is very common, very treatable, and I want to address it properly. The other thing that's happening is that the daily pain relief has created a second type of headache on top of the migraine — a rebound cycle. Both need treatment, and they're connected."
Deductions
  • Diagnosing only MOH without naming the underlying migraine with aura — the OCP needs to stop based on the aura, not the MOH; both diagnoses must be communicated
6
Step 6
Referral — Neurology · Ophthalmology (GCA) · Tertiary Headache Services
collapse
Most headache is managed entirely in primary care. Specialist referral is indicated for: diagnostic uncertainty with red flags; refractory migraine after two adequate prophylactic trials; cluster headache (neurology for verapamil titration); GCA (rheumatology/ophthalmology); IIH (neurology for LP and monitoring); suspected intracranial pathology; hemiplegic or basilar migraine.
IndicationUrgencyWhat GP does before referralWhat NOT to do
GCA — same-day ophthalmology if visual symptomsSame day if visual symptomsStart prednisolone 60mg OD immediately (do NOT wait for referral appointment); arrange ESR + CRP; temporal artery biopsy referral within 2 weeks; ophthalmology same day if any visual loss, amaurosis fugax, or diplopia. Initiate bone protection (calcium + vitamin D; DEXA). PPI for GI protection on high-dose steroids.Do NOT wait for ESR or biopsy result before starting steroids. Do NOT delay prednisolone by even 24 hours — anterior ischaemic optic neuropathy can cause permanent bilateral visual loss within hours of the initial vision warning.
Neurology — headache specialist referralRoutine — 4–6 weeksIndications: diagnostic uncertainty; two failed prophylactic trials; cluster headache (for verapamil management); hemiplegic or basilar migraine; headache frequency not controlled despite adequate treatment. Provide complete headache diary, treatment history, and investigations performed. Tertiary headache centres: CGRP antagonist or anti-CGRP monoclonal antibody eligibility assessment (erenumab, fremanezumab — NICE approved for preventive treatment in chronic migraine failing 3 preventives).Do NOT refer without a trial of at least one appropriate prophylactic agent. Do NOT refer for normal routine migraine — manage in primary care per NICE guidance first. Do NOT prescribe anti-CGRP agents in primary care — specialist-only.
Neurology — IIH or raised ICP suspectedUrgent — 2–4 weeks; same day if severe visual lossCT/MRI brain before referral if available quickly; fundoscopy to document papilloedema; weight loss advice; withhold any medication that raises ICP (tetracyclines — doxycycline, minocycline; steroids paradoxically worsen IIH; nitrofurantoin; vitamin A excess). Acetazolamide: consider initiating with specialist guidance. URGENT if visual field defects — optic nerve sheath fenestration may be required to preserve vision.Do NOT prescribe tetracyclines in patients with IIH (markedly worsen IIH). Do NOT delay referral if papilloedema is confirmed — visual loss from IIH can be permanent and sudden.
🎓 SCA Checkpoint — Step 6Tasks
When to reassure no referral needed
"For migraine — which is what you have — most people are managed very well in primary care. Referral to a neurologist is not routine; it's something I'd consider if we've tried two preventive medications and they haven't worked. Today we're going to start by tackling the medication overuse and putting the right treatments in place."
Deductions
  • Referring Rachel to neurology before any primary care treatment attempt — this is premature and not guideline-compliant; primary care treatment should be optimised first
7
Step 7
Management — MOH Withdrawal · OCP Stop · Triptan · Prophylaxis · Lifestyle
collapse
7A — Address expectations: why stronger painkillers will make things worse
💊
Validate the pain. Explain the paradox. Offer a real treatment plan.
1
Validate the pain before explaining the cause

Rachel is in genuine pain every day. Starting with "the analgesics are causing your headaches" before acknowledging the real suffering feels dismissive. Begin with: "I can see you've been managing this on your own for 3 months, in real pain, while teaching — that's very hard." Then explain.

"I want to say first: the headaches are real and I can see how much they've been affecting you. I'm not going to minimise that or tell you it's stress. There is a real explanation for what's happening and there is a treatment — but it's not what you were expecting."
2
Explain MOH mechanistically — the rebound trap

The MOH explanation must be specific and mechanistic, not a vague "painkillers can cause headaches." Rachel needs to understand the neurobiological reason — otherwise she will not believe it. The analogy: "your brain's pain thermostat has been overridden by the daily painkillers; without them, the thermostat fires at a lower threshold, generating pain." Concrete and visual.

"What has happened is that your brain has become used to having pain relief in the system every day. When the painkiller wears off, the pain-signalling system in your brain fires more intensely than it should. You take more painkiller, it damps it down, but the baseline gets worse. After 3 months of daily use, the medication is the main thing driving the daily headaches."
3
Offer a structured plan with a specific timeline

Telling someone to "stop all pain relief" without a structured plan and bridge medication is inadequate and will fail. The plan has four components: (1) stop all analgesics simultaneously; (2) bridge with naproxen or prednisolone for 2 weeks; (3) add preventive medication (amitriptyline or propranolol); (4) review at 2 weeks with headache diary. The timeline: "the next 10 days will be harder; most people see significant improvement by week 3–4."

"Here is what I want to do: stop the paracetamol and codeine completely, give you a short 2-week course of naproxen as a bridge that doesn't cause rebound, start a preventive medication to reduce how often the migraines come, and see you in 2 weeks. Most people who do this say 4 weeks later they feel dramatically better. I'll be here to support you through it."
7B — Treatment goals
Today's treatment priorities (Rachel)
Stop combined OCP today — UKMEC 4 (migraine with aura); prescribe progestogen-only pill (desogestrel 75mcg)Explain and initiate MOH withdrawal — stop paracetamol and codeine simultaneously Bridge analgesic: naproxen 500mg BD × 2 weeks (does not cause MOH at this duration)Start migraine prophylaxis: amitriptyline 10mg nocte (titrate to 75mg if tolerated) or propranolol 40mg BD Acute migraine treatment: sumatriptan 50mg at onset (NOT during withdrawal — use after withdrawal complete)Headache diary: Migraine Buddy app or paper diary; count days, severity, analgesic use Review in 2 weeks: withdrawal progress; headache frequency; mood; sleepLifestyle: consistent sleep-wake; stress management; identify triggers; alcohol reduction
What to say about the aura and the OCP
"The visual zigzag is migraine aura — and with aura, the combined pill carries a significant stroke risk. I need to stop the Microgynon today and give you a different contraceptive that doesn't have this risk."
"The progestogen-only pill — Cerazette — is just as effective for contraception, does not increase stroke risk in migraine with aura, and is safe to start today. Some people find it slightly changes their cycle but most tolerate it very well."
7C — Lifestyle management
😴
Sleep Regulation
Same wake time daily; 7–9 hours; no lie-ins
Why it matters

Sleep changes — both deprivation and oversleeping — are among the most potent migraine triggers. The mechanism: serotonin and other neurotransmitters involved in migraine are reset during sleep. Irregular sleep times disrupt this resetting. Weekend lie-ins are a common but under-recognised migraine trigger. Consistent wake time (even at weekends) stabilises the circadian rhythm and reduces attack frequency significantly in many patients.

Practical

Same wake time every day including weekends. Screen/phone off 60 minutes before bed (blue light inhibits melatonin; cognitive arousal delays sleep onset). Avoid caffeine after 2pm. No alcohol within 3 hours of sleep (fragments sleep architecture). Cool, dark, quiet bedroom. Consistent sleep is one of the most effective migraine prevention strategies — free, no side effects.

Consistent sleep schedule: reduces migraine frequency by up to 50% in sleep-sensitive patients
🍽️
Diet and Hydration
Regular meals; 2L water/day; limit alcohol
Common triggers

Skipping meals (hypoglycaemia): very common trigger; eat at regular intervals; always eat breakfast. Dehydration: 2L water minimum/day; headache often precipitated by mild dehydration. Alcohol: ethanol vasodilator + causes dehydration + contains tyramine and histamine (red wine especially). Caffeine: regular users — skipping morning coffee causes withdrawal headache; gradually reduce rather than abrupt cessation. Tyramine-rich foods: aged cheese, cured meats, fermented foods — trigger in susceptible patients; headache diary identifies individual triggers.

Headache diary

A headache diary prospectively identifies dietary triggers. Not all patients have food triggers — asking the patient to avoid all "migraine foods" without evidence of personal trigger is unnecessary restriction. Use the diary to identify individual patterns.

Meal regularity + hydration: reduces attack frequency in ~40% of trigger-sensitive patients
🧘
Stress Management
CBT; relaxation; biofeedback; exercise
Stress as trigger

Stress is the single most commonly reported migraine trigger (reported by ~70% of migraine sufferers). Stress activates the hypothalamic-pituitary-adrenal axis, releases cortisol and catecholamines, and lowers the threshold for trigeminal pain activation. Both the acute stress (trigger) and the "let-down" after stress subsides (weekend migraine pattern after a stressful week) can trigger attacks. Addressing Rachel's work stress is both a wellbeing and a migraine management intervention.

CBT evidence

Cognitive behavioural therapy for headache: evidence-based; shown in RCTs to reduce migraine frequency comparably to pharmacological prophylaxis; especially effective when anxiety and pain catastrophising are present. NHS Talking Therapies referral (Improving Access to Psychological Therapies): available on NHS; low-intensity CBT for headache and stress. Mindfulness-based stress reduction (MBSR): evidence for chronic pain.

CBT: reduces headache frequency by 35–50% in studies; equivalent to some pharmacological prophylactics
🏃
Exercise
150 min/week moderate; reduces frequency
Evidence

Regular aerobic exercise reduces migraine frequency significantly in RCTs — comparable to topiramate in one head-to-head comparison. Mechanism: releases endogenous endorphins and endocannabinoids; reduces cortisol; improves sleep; reduces body weight (adipokines and inflammatory cytokines from adipose tissue are migraine triggers). CAUTION: vigorous sudden exercise can trigger migraine in some patients (exercise-triggered migraine); warm up gradually; pre-exercise hydration and nutrition.

Practical

Start gradually: walking → cycling → swimming → more vigorous. Pre-exercise: small snack; 500ml water; adequate warm-up. If exercise regularly triggers migraine: consider low-dose triptan pre-exercise on high-risk days. 150 minutes/week moderate intensity as a target.

Regular aerobic exercise: comparable to topiramate in reducing migraine frequency in one RCT
📱
Headache Diary and Trigger Tracking
Migraine Buddy app; paper diary; 4–8 weeks baseline
What to record

Daily diary for 4–8 weeks: presence of headache (yes/no); severity (1–10); duration; features (nausea, visual symptoms, side); analgesic use (type, dose, time); potential triggers (stress level, sleep hours, meals, hydration, alcohol, period, exercise, weather); response to treatment. The diary serves dual purposes: diagnostic tool (confirms headache type and frequency; identifies MOH) and therapeutic tool (gives patients agency; identifies individual triggers; motivates lifestyle changes when patterns become visible).

Apps

Migraine Buddy, Migraine Monitor, N1-Headache: validated; free or low cost; syncs with Apple Health/Google Fit. Paper version equally effective. Ask to bring diary to every review appointment.

Headache diary: identifies MOH pattern; quantifies treatment response; empowers patient self-management
🚫
Analgesic Withdrawal Plan
Stop all analgesics simultaneously; bridge 2 weeks
Withdrawal method

Stop all analgesics (paracetamol, codeine, NSAIDs) simultaneously (not one at a time — gradual withdrawal prolongs the process). Expected withdrawal period: 7–14 days of worsening headache — warn Rachel explicitly; if not warned, she will restart analgesics at day 3 when headaches peak. Bridge analgesic: naproxen 500mg BD (taken regularly, not PRN) for 2 weeks — naproxen at this duration does not cause MOH; OR prednisolone 40–50mg OD × 5 days (reduces withdrawal severity; especially useful if work commitments make severe withdrawal intolerable). Do NOT use codeine, tramadol, or triptan as bridge — all cause MOH.

Support during withdrawal

Review at 2 weeks: headache diary; compliance; mood check (depression common during withdrawal; PHQ-9). Anti-emetics: domperidone or prochlorperazine for nausea during withdrawal. Letter for employer/school if significant withdrawal illness affects work attendance.

MOH withdrawal: >70% of patients revert to episodic headache pattern after successful withdrawal
7D — Prescribing guide
Headache prescribing has three components: (1) acute attack treatment (triptan, aspirin + metoclopramide); (2) prophylaxis if frequent (amitriptyline, propranolol, topiramate); (3) cluster headache treatment (O2, subcutaneous sumatriptan, verapamil). GCA requires immediate high-dose prednisolone — the most time-critical prescribing decision in headache medicine.
Acute Migraine — NICE First-Line
  • Aspirin 900mg + metoclopramide 10mg: NICE first-line for migraine acute treatment; aspirin absorbed faster with metoclopramide (gastric stasis of migraine); efficacy equivalent to oral triptans in most patients; cheaper; no rebound at normal dosing frequency
  • Ibuprofen 400mg: alternative NSAID; effective for mild-moderate attacks
  • Take at onset of HEADACHE (not during aura): taking during aura does not help aura and delays absorption; take when headache begins
  • MOH threshold: simple analgesics >15 days/month → MOH risk; restrict to ≤2 days/week maximum
Triptans — Second-Line Acute
  • Sumatriptan 50–100mg oral: first-line triptan; onset 30 min; second dose at 2h if partial response; max 200mg/day. Also available: nasal spray 20mg (faster onset; useful with nausea); subcutaneous 6mg (fastest; 10 minutes; cluster headache)
  • Take at onset of headache (NOT during aura) — taking during aura does not abort the headache and may reduce efficacy
  • Triptan failure: try different triptan (responder profile varies); zolmitriptan, rizatriptan, eletriptan, almotriptan; try different route if oral fails (nasal, SC)
  • MOH threshold: >10 days/month → triptan MOH
  • Contraindications: uncontrolled hypertension; ischaemic heart disease; prior stroke/TIA; hemiplegic or basilar migraine; MAOIs; pregnancy (relative CI)
GCA — Immediate Prednisolone (Most Urgent Prescribing in Headache)
  • Prednisolone 40–60mg OD: start IMMEDIATELY on clinical diagnosis of GCA; 60mg if visual symptoms (higher risk of optic neuropathy). Do NOT wait for ESR/biopsy
  • Bone protection from day 1: calcium 1000mg + vitamin D 800IU; DEXA; bisphosphonate (alendronate) if T-score <-2.0; PPI (omeprazole 20mg) for GI protection
  • Taper: guided by rheumatology; typical initial taper to 20mg by 3 months; total duration often 1–2 years; taper guided by symptoms and CRP/ESR
  • Aspirin 75mg: some evidence for additional protection against ischaemic complications in GCA while on steroids
Migraine Prophylaxis — Indications and Options
  • Prophylaxis indications (NICE): ≥4 headache days/month significantly impacting QoL; failing to respond to adequate acute treatment; frequent use of acute medications (MOH risk); patient preference; specific subtypes (hemiplegic migraine, migraine with prolonged aura)
  • Propranolol 40mg BD (up to 160mg BD): beta-blocker; first-line; evidence base; also treats hypertension and anxiety. Contraindicated: asthma, COPD, heart block, peripheral vascular disease, diabetes (masks hypoglycaemia)
  • Amitriptyline 10mg nocte (titrate to 75mg): tricyclic; evidence for migraine + TTH prophylaxis; dual benefit if depression or poor sleep present; side effects: dry mouth, drowsiness, constipation, weight gain. Take at 22:00 (6–8 hours before waking)
  • Topiramate 25–100mg OD: highly effective; TERATOGENIC — not in pregnancy or if not using highly effective contraception; side effects: "dopamax" (cognitive dulling, word-finding difficulties), paraesthesia, weight loss, kidney stones, metabolic acidosis; MHRA warning 2024 — mandatory contraception requirement
Cluster Headache Specific Management
  • Acute attack — 100% oxygen 12–15 L/min via NRB mask × 15–20 min: most effective and fastest acute treatment; prescribe home O2 concentrator (not cylinders — inadequate flow rate); onset 5–10 minutes; response rate ~70%
  • Subcutaneous sumatriptan 6mg: fastest triptan route; onset 10–15 min; max 2 injections/24 hours. Nasal sumatriptan 20mg: alternative if SC not tolerated
  • Oral analgesics NOT effective: too slow for 45-minute cluster attack; do not prescribe codeine or paracetamol for cluster
  • Prophylaxis — verapamil SR 240–480mg/day: first-line for cluster prevention; start at onset of cluster period; titrate up; ECG monitoring (AV block risk); refer neurology for management
  • Short-course prednisolone 60mg × 5 days: rapidly breaks a cluster period; bridge while verapamil reaches therapeutic level
7E — Medication selector

Select headache scenario — personalised treatment recommendation

Treatment recommendation
Migraine with aura + OCP: STOP combined OCP immediately (UKMEC 4); prescribe desogestrel 75mcg (progestogen-only). MOH withdrawal: stop ALL analgesics simultaneously; bridge naproxen 500mg BD × 2 weeks OR prednisolone 40mg × 5 days; add prophylaxis. Migraine acute: aspirin 900mg + metoclopramide 10mg (first-line) OR sumatriptan 50–100mg (not during aura; restrict ≤10 days/month). Prophylaxis (≥4/month): propranolol 40mg BD (first-line) OR amitriptyline 10–75mg nocte. Topiramate: highly effective but TERATOGENIC — not in women of childbearing potential without highly effective contraception; MHRA 2024 warning. Cluster: 100% O2 12–15 L/min NRB mask × 15–20 min (prescribe O2 concentrator) + sumatriptan SC 6mg; prophylaxis: verapamil SR. GCA: prednisolone 40–60mg OD IMMEDIATELY — do not wait for biopsy or ESR. Pregnancy: paracetamol acutely (safest); avoid NSAIDs after 20 weeks; avoid triptans (limited data); topiramate and valproate ABSOLUTELY CONTRAINDICATED.
7F — Drug reference cards
Sumatriptan (5-HT1B/1D Agonist — Triptan)
Oral 50–100mg · Nasal spray 20mg · Subcutaneous 6mg (cluster) · First-line triptan
✓ Acute migraine — triptan if NSAID + metoclopramide fails or severe
Second-line acute migraine; cluster SCOral 50–100mg at headache onset; repeat 100mg after 2h if partial response; max 300mg/day; SC 6mg for cluster
✓ When to use
Moderate-severe migraine not responding to aspirin + metoclopramide; first-line for cluster headache (SC route); rapid onset needed. NICE: offer triptan to all migraine patients who fail simple analgesia. Triptan + anti-emetic together is more effective than triptan alone (gastric stasis of migraine delays oral absorption). SC sumatriptan: fastest onset (10 min); used for cluster; useful for severe migraine with vomiting. Nasal spray: faster than oral; useful when oral not feasible.
✗ Contraindications
Uncontrolled hypertension; ischaemic heart disease (angina, prior MI); prior stroke or TIA; peripheral vascular disease; hemiplegic migraine or basilar migraine (risk of stroke); MAOIs within 2 weeks; ergotamine within 24 hours.
Pregnancy: limited data; generally avoided; sumatriptan has most safety data if essential. SSRI/SNRI: serotonin syndrome risk (caution at normal doses; not absolute CI). Migraine with aura: sumatriptan is SAFE in migraine with aura (unlike combined OCP); do not withhold triptan because of aura.
⚠ Side effects and MOH
Chest tightness/pressure (5–10% — vasoconstrictive effect; usually benign; investigate if cardiac risk factors). Tingling, warmth, heaviness. Flushing. Nausea. Injection site reactions (SC). MOH threshold: >10 days/month → triptan MOH; restrict use to ≤2 days/week maximum. Rebound headache if overused: triptan MOH has a shorter threshold than analgesic MOH.
🔬 Monitor
Headache diary: count triptan use days per month; if >10 days/month → MOH developing; withdraw all triptans as part of MOH treatment. BP before prescribing. Review acute treatment response at 4–6 weeks. Switching triptan: if sumatriptan fails at adequate dose, try another triptan class (zolmitriptan, rizatriptan, eletriptan — different pharmacokinetics; individual response varies).
💬 Counselling

"Take the triptan at the start of the headache — not during the visual symptoms before it (the aura), because it won't work then and you'll use up your dose early. Take it as soon as the headache begins. If you get some relief in 2 hours but the headache comes back, you can take a second dose. Try not to take it more than 2 days a week — if you use it more often than that, the tablet itself can start to cause headaches. Always take an anti-nausea tablet with it if nausea is part of your migraine."

Sumatriptan: SAFE in migraine with aura (unlike combined OCP). Take at HEADACHE onset — NOT during aura. MOH threshold: >10 days/month. SC route for cluster (fastest onset). Contraindicated in ischaemic heart disease, prior stroke/TIA, hemiplegic migraine, uncontrolled hypertension, MAOIs. SSRI + triptan: caution (serotonin syndrome — not absolute CI at normal doses). Do NOT use as bridge in MOH withdrawal — it causes MOH.

Propranolol (Beta-Blocker Prophylaxis)
40mg BD initially · Titrate to 40–80mg TDS or 160mg BD (modified release) · Migraine prevention first-line
✓ First-line migraine prophylaxis — NICE; dual benefit in anxiety and hypertension
First-line migraine prophylaxis; ≥4 days/monthStart 40mg BD; titrate to 40–80mg TDS or Inderal LA 80mg; target dose guided by response and toleration
✓ When to prefer propranolol
NICE first-line migraine prophylaxis; evidence base from multiple RCTs; approximately 50% of patients achieve ≥50% reduction in migraine frequency. Dual benefit when: hypertension present (treats both); anxiety present (reduces somatic anxiety symptoms); performance anxiety (situational dose). Start at lowest dose and titrate over 4–6 weeks. Allow 8–12 weeks at therapeutic dose before assessing response. Continue for minimum 6 months then review.
✗ Contraindications
Asthma and COPD: ABSOLUTELY CONTRAINDICATED (bronchospasm); check respiratory history before prescribing. Bradycardia or heart block (HR <60; PR interval prolonged). Uncontrolled heart failure. Peripheral vascular disease (intermittent claudication).
Diabetes: masks hypoglycaemia (sweating preserved; other symptoms masked); use with caution; not absolute CI. Depression: may worsen (check PHQ-9 at initiation). Erectile dysfunction: can cause or worsen.
⚠ Side effects
Fatigue (most common; often resolves after 2–4 weeks). Cold peripheries. Sleep disturbance; vivid dreams. Bradycardia. Hypotension. Erectile dysfunction in men. Weight gain. Do NOT stop abruptly (rebound hypertension; cardiac risk; worsening angina if IHD): taper over 2 weeks.
🔬 Monitor
BP and HR at 4–6 weeks; maintain HR >50 at rest. Headache diary: assess response at 8–12 weeks at therapeutic dose. PHQ-9: depression at initiation and review. If inadequate response after adequate trial: switch to amitriptyline or topiramate; do not increase beyond maximum therapeutic dose without reviewing indication.
💬 Counselling

"This tablet is a preventive — you take it every day regardless of headaches. It's not for the acute pain; it's to reduce how often the migraines happen. It typically takes 6–8 weeks to see the full effect, so please don't stop it before then if you don't notice a difference straight away. The most common side effect in the first few weeks is tiredness — this usually settles. Please don't stop it suddenly — come to see me first if you want to stop, because we'll need to reduce it gradually."

Propranolol: NICE first-line migraine prophylaxis. Absolutely contraindicated in asthma/COPD. Takes 8–12 weeks for full response — counsel on this. Do not stop abruptly (rebound). Dual benefit: hypertension + migraine; anxiety + migraine. Alternative if asthma/COPD: amitriptyline. Check HR before each dose increase (target HR >50 rest). Titrate gradually to effective dose (up to 160mg BD modified release).

Topiramate (Anticonvulsant Prophylaxis)
25mg OD initially · Target 50–100mg/day · Migraine prevention · TERATOGENIC — MHRA 2024 warning
✓ Highly effective migraine prophylaxis — MHRA 2024: NOT in pregnancy; mandatory contraception
Migraine prophylaxis; NOT in pregnancy; contraception mandatoryStart 25mg OD; increase by 25mg every 2 weeks; target 50–100mg/day; max 200mg/day
✓ Efficacy
Highly effective migraine prophylaxis (comparable to propranolol in RCTs); also licensed for chronic migraine and episodic migraine prevention. Mechanism: voltage-gated sodium channel blockade; enhances GABA; reduces trigeminal pain. Weight loss side effect is therapeutically beneficial if patient is obese. Approved for migraine prophylaxis (not just epilepsy) — prescribe as migraine preventive, not off-label.
⛔ TERATOGENICITY — MHRA 2024 WARNING
TERATOGENIC: significantly increased risk of cleft palate, cleft lip, hypospadias, and other congenital malformations (approximately 2–4× increased background risk). Neural tube defects. Neurodevelopmental problems (lower IQ, autism spectrum disorder) in exposed children. MHRA 2024: topiramate MUST NOT be prescribed to women of childbearing potential unless: they are using highly effective contraception (implant, IUS, or injectable hormonal; NOT OCP alone which topiramate reduces efficacy of via CYP3A4 induction) AND they understand the teratogenic risk AND they are enrolled in a pregnancy prevention programme. Pregnancy test before starting. Document annual review of contraceptive status.
OCP + topiramate: topiramate induces CYP3A4 → reduces OCP plasma levels → contraceptive failure risk → pregnancy at teratogenic exposure risk. Do NOT rely on OCP alone as contraception with topiramate.
⚠ Common side effects — "Dopamax"
Cognitive dulling — "dopamax" effect: word-finding difficulties, slowed thinking, poor concentration (most common reason for discontinuation; 15–30% of patients; dose-related; titrating slowly reduces severity). Paraesthesia (tingling in hands and feet — very common; benign; usually resolves). Weight loss. Kidney stones (carbonic anhydrase inhibition → urinary alkalinisation → calcium phosphate stones): increase fluid intake; avoid high-sodium diet. Metabolic acidosis: measure bicarbonate if symptomatic. Glaucoma (rare; acute angle closure — stop if eye pain or visual change).
🔬 Monitor
Annual review: contraceptive status (pregnancy prevention programme); cognitive side effects (PHQ-9; word-finding difficulties); weight; renal function + bicarbonate (metabolic acidosis screen). Pregnancy test before initiation. If pregnancy occurs while on topiramate: refer urgently to obstetrics and neurology; do not stop abruptly without specialist advice.
💬 Counselling (teratogenicity)

"I want to tell you about an important requirement before I prescribe this medication. Topiramate can cause serious problems for a developing baby if you were to become pregnant while taking it — including effects on brain development. Because of this, I need to know you're using highly effective contraception — not just the pill on its own, as this medication slightly reduces how well the pill works. The best options are an implant or a coil. We'll review your contraception every year. If you're planning a pregnancy, please talk to me first — we'll switch to a different preventive medication."

Topiramate: TERATOGENIC — MHRA 2024 mandatory pregnancy prevention programme for all women of childbearing potential. DO NOT use with OCP alone (reduces OCP efficacy → pregnancy risk). Require highly effective contraception (implant, IUS). "Dopamax" cognitive side effects: word-finding, slowed thinking (dose-dependent; titrate slowly). Kidney stones: increase fluids. Metabolic acidosis: check bicarbonate. Glaucoma (rare): stop if eye pain. Do NOT use in pregnancy; switch to propranolol or amitriptyline.

Amitriptyline (Tricyclic Antidepressant — Prophylaxis)
10mg nocte initially · Titrate to 10–75mg nocte · Migraine + TTH prophylaxis · Dual benefit if depression/sleep disorder
✓ Migraine and TTH prophylaxis; best evidence for TTH prevention; antidepressant dual benefit
Migraine and TTH prophylaxis; first-line if depression or poor sleepStart 10mg at 22:00; increase by 10mg every 2 weeks; effective dose typically 30–75mg; max 75–150mg; taken at night (anticholinergic sedation)
✓ When to prefer amitriptyline
Best evidence for TTH prophylaxis (first-line per NICE for chronic TTH). Also effective for migraine prophylaxis. Ideal when: depression or anxiety present (dual benefit); poor sleep (sedating effect used therapeutically — taken at 22:00); asthma/COPD (unlike propranolol); chronic pain comorbidity (neuropathic pain; fibromyalgia). Low dose as prophylaxis (10–75mg) has analgesic and serotonin/noradrenaline effects distinct from antidepressant effect at higher doses.
✗ Contraindications and cautions
Recent myocardial infarction; cardiac arrhythmias (especially QTc prolongation — amitriptyline prolongs QT); severe liver disease; MAOI use or within 2 weeks (serotonin syndrome).
Elderly: high fall risk (postural hypotension; sedation); use with caution; start at 5–10mg; consider nortriptyline (less anticholinergic) instead. Benign prostatic hypertrophy: anticholinergic → urinary retention. Glaucoma: anticholinergic → raised intraocular pressure. Avoid in bipolar disorder without mood stabiliser.
⚠ Side effects
Morning grogginess (most common; dose-dependent; take earlier in evening at 21:00–22:00; reduces with time). Dry mouth. Constipation. Weight gain. Blurred vision. Urinary hesitancy. Postural hypotension. QT prolongation (ECG if high-dose or cardiac risk). Anticholinergic effects generally dose-dependent; titrate slowly.
🔬 Monitor
PHQ-9: reassess depression at 4–6 weeks. Headache diary: assess prophylactic response at 8–12 weeks at stable dose. Weight. BP (postural). If no response after 75mg × 3 months: switch prophylactic. Gradual withdrawal if stopping (psychiatric symptoms with abrupt discontinuation). ECG if >75mg/day or cardiac risk.
💬 Counselling

"This tablet is taken at bedtime — usually around 10pm. We're using it at a low dose for headache prevention, not as a full antidepressant, though it can also help mood and sleep. The most common side effect is feeling groggy in the morning — this usually settles after 2–3 weeks. Dry mouth is common. It takes 6–8 weeks to see the preventive effect on headaches, so please give it time. Don't stop it suddenly — let me know if you want to stop and we'll taper gradually."

Amitriptyline: first-line TTH prophylaxis; also effective for migraine. Take at 22:00 (not morning — sedation used therapeutically). Titrate from 10mg; effective dose 30–75mg. Best choice when depression or poor sleep coexist with headache. Morning grogginess is most common side effect (settles in 2–3 weeks). Contraindicated in recent MI, arrhythmias, MAOIs. MHRA: QT prolongation risk at higher doses — ECG if dose >75mg. Do NOT stop abruptly.

High-Flow Oxygen (Cluster Headache Acute Treatment)
100% O2 · 12–15 L/min · Non-rebreather mask · 15–20 minutes · O2 concentrator for home use
✓ Most effective acute treatment for cluster headache — prescribe home O2 concentrator
Cluster headache acute — first-line; onset 5–10 minutes100% O2 via non-rebreather mask at 12–15 L/min for 15–20 minutes at onset of attack
✓ Why oxygen works for cluster headache
Mechanism: high-flow oxygen causes cerebral vasoconstriction (cluster attacks associated with cranial vascular dilation and CGRP release); directly inhibits trigeminal nucleus activity. Effective in ~70% of cluster attacks; onset 5–10 minutes. Response rate superior to oral analgesics (too slow for 45-minute attack) and comparable to subcutaneous sumatriptan but safer for frequent use. NICE recommends as first-line for cluster headache acute treatment alongside sumatriptan. Prescribe an oxygen concentrator for home use (provides continuous flow; more practical than cylinders which have limited volume; prescribe via FP10 oxygen prescribing service).
✗ Common prescribing error
Prescribing oxygen cylinders instead of a concentrator: oxygen cylinders have limited volume (insufficient for multiple attacks per day in a cluster period); concentrators provide continuous unlimited flow. Prescribing low-flow oxygen (2–4 L/min via nasal cannula): INEFFECTIVE; must be 12–15 L/min via non-rebreather mask. Using ambulatory cylinders from a home care company: check the flow rate can reach 15 L/min (some smaller portable cylinders cannot achieve this).
COPD with CO2 retention: high-flow O2 may worsen hypercapnia — caution; seek pulmonology advice; sumatriptan SC is the safer alternative in COPD cluster.
⚠ Practical requirements
Concentrator: prescribed via FP10 oxygen home prescribing form; arrange through community oxygen service. Non-rebreather mask: essential (one-way valves prevent CO2 rebreathing; ensures near 100% O2 delivery). Sitting upright, leaning slightly forward during treatment (maximises response). Allow 20 minutes at full flow — stopping early reduces response rates. Concurrent SC sumatriptan: if O2 partially effective, SC sumatriptan 6mg can be used for breakthrough attacks.
🔬 Monitor
Oxygen response rate: document at each cluster review (if <50% response rate: add or switch to SC sumatriptan). Cluster period duration: most last 4–12 weeks; episodic cluster; predict next cluster season (many patients get clusters at same time of year). Prophylaxis review: verapamil efficacy and dose; ECG for AV block. Neurology referral if poorly controlled.
💬 Counselling

"As soon as you feel an attack starting, put on the mask — make sure it covers your nose and mouth with no gaps — and turn the flow rate to 15 litres per minute. Sit upright leaning slightly forward. Breathe normally through the mask. Keep it on for 15 to 20 minutes — most people feel significant relief within 10 minutes. If you stop early the headache may come back. The concentrator plugs in at home; you can also use it in any room. Keep the mask and concentrator by your bed for the night attacks."

Cluster headache acute: 100% O2 12–15 L/min via non-rebreather mask (NOT nasal cannula); 15–20 minutes. Prescribe O2 CONCENTRATOR (not cylinders — insufficient volume for daily cluster attacks). ~70% response rate; onset 5–10 min. Concurrent SC sumatriptan 6mg as alternative/adjunct. Oral analgesics are INEFFECTIVE (too slow for cluster attacks). Prophylaxis: verapamil SR (ECG monitoring for AV block). Refer neurology for cluster management. COPD: O2 risk — use sumatriptan SC instead.

Prednisolone (GCA + Cluster Bridge + MOH Withdrawal)
GCA: 40–60mg OD; Cluster bridge: 60mg × 5 days; MOH withdrawal bridge: 40–50mg × 5 days
✓ GCA: most time-critical prescription in headache medicine — start before investigation results
GCA: START IMMEDIATELY; Cluster bridge; MOH withdrawal bridgeGCA: 40mg OD (no visual symptoms) or 60mg OD (visual symptoms); Cluster bridge: 60mg OD × 5 days then taper; MOH: 40–50mg OD × 5 days
✓ Three indications in headache medicine
GCA (most urgent): Prednisolone 40–60mg OD immediately on clinical diagnosis. Visual symptoms → 60mg. Do NOT wait for ESR, CRP, or biopsy result. Risk of bilateral permanent visual loss from anterior ischaemic optic neuropathy within hours of warning symptoms. Long-term course (typically 1–2 years) guided by rheumatology; taper guided by symptoms and CRP/ESR.
Cluster headache bridge: Prednisolone 60mg OD × 3–5 days then taper over 2–3 weeks; used at start of cluster period while verapamil reaches therapeutic level (2–4 weeks). Short course; rapid and effective cluster period reduction.
MOH withdrawal: Prednisolone 40–50mg OD × 5 days; reduces withdrawal headache severity; particularly useful if withdrawal headaches would prevent work; short course; effective in RCTs as bridge during analgesic cessation.
✗ GCA: never delay steroids
Never delay prednisolone in GCA for ESR/biopsy result — anterior ischaemic optic neuropathy can cause irreversible bilateral blindness within hours. Once steroids are started, temporal artery biopsy can be arranged within 2 weeks (histological changes persist). The temporal artery biopsy confirms diagnosis but never delays treatment.
⚠ GCA: long-term steroid side effects
Osteoporosis (most important long-term risk): calcium 1000mg + vitamin D 800IU from day 1; DEXA; bisphosphonate if T-score <-2.0 or prednisolone >7.5mg/day >3 months. GI: PPI (omeprazole 20mg) from day 1. Diabetes: blood glucose monitoring; may require insulin. Hypertension: BP monitoring. Adrenal insufficiency on tapering: taper slowly; illness rules (sick day rules). Infections: increased risk; pneumococcal, flu, shingles vaccines. Cataract, glaucoma: annual eye check. Weight gain, mood changes, insomnia, avascular necrosis (hip — report hip pain).
🔬 Monitoring for long-term GCA steroids
GCA: ESR + CRP at 2–4 weeks (confirms response); then at each taper; PMR symptoms (shoulder/hip girdle ache — PMR co-exists in 40–50% of GCA); BP; blood glucose; weight; DEXA; ophthalmology follow-up; rheumatology shared care. Temporal artery biopsy: arrange within 2 weeks of starting steroids.
💬 Counselling (GCA)

"I'm starting you on prednisolone today because there is a small but real risk of permanent vision loss if we wait. The steroids should prevent that. I know this is a high dose — I want to explain what we need to watch for: we'll monitor your blood pressure and blood sugars, and I'm going to prescribe a stomach-protecting tablet and calcium tablets alongside them. We'll arrange a biopsy of the temporal artery within the next 2 weeks to confirm the diagnosis. Do not stop the prednisolone without talking to me first."

GCA: prednisolone IMMEDIATELY — the most time-critical prescribing decision in all of headache medicine. Visual symptoms → 60mg (not 40mg). Never delay for ESR or biopsy. Co-prescribe from day 1: PPI + calcium/vitamin D + blood glucose monitoring plan. Long-term: DEXA + bisphosphonate; sick day rules; steroid card. Cluster bridge: 60mg × 5 days while verapamil titrates. MOH withdrawal bridge: 40mg × 5 days reduces withdrawal severity and improves analgesic cessation success rate.

7G — Psychosocial impact of chronic headache
🫂
Chronic daily headache — the invisible disability
Chronic migraine and chronic daily headache impose a disability burden comparable to depression and equivalent to conditions such as congestive heart failure in terms of quality of life impairment. Rachel has been functioning as a teacher, managing classes, planning lessons, and maintaining professional relationships while in daily pain. The consultation that treats only the headache biology — without addressing the disability, the employment impact, the sleep disruption, and the psychological toll — is clinically incomplete.
🏫
Occupational Impact

Teaching requires sustained concentration, voice projection, behaviour management, and emotional regulation — all significantly impaired by daily headache and analgesic-induced cognitive dulling. Rachel's ability to function at work is being undermined both by the headaches and by the opioid analgesia (codeine causes cognitive impairment at therapeutic doses).

"I want to acknowledge that managing daily headaches while teaching is genuinely difficult — you've been doing it on your own for 3 months. The codeine makes it harder too, because it dulls concentration. Once we get through the withdrawal, your ability to think clearly at work should improve alongside the headaches."
😔
Depression and Anxiety Comorbidity

Up to 50% of patients with chronic daily headache have comorbid depression; up to 40% have significant anxiety. The relationship is bidirectional: depression lowers pain threshold; headache perpetuates depression through sleep disruption, social withdrawal, and occupational impairment. PHQ-9 and GAD-7 at every chronic headache consultation. Amitriptyline for prophylaxis has dual benefit if depression is present.

"I want to ask about your mood alongside the headaches — the two often go together, and it's not weakness to acknowledge it. How have you been feeling emotionally?"
🛏️
Sleep Disruption

Headaches both disrupt sleep and are worsened by poor sleep. The vicious cycle: headache → pain at night → fragmented sleep → next-day fatigue → lowered pain threshold → more headaches. Codeine at therapeutic doses disrupts sleep architecture (reduces REM sleep). Sleep hygiene intervention is both a lifestyle and a pharmacological withdrawal support measure.

"The codeine you're taking at night actually disrupts sleep — it reduces deep sleep and REM sleep, which is why you're probably not waking refreshed even when you sleep 8 hours. Part of stopping the codeine is getting your sleep quality back."
🤝
Withdrawal Support and Motivation

MOH withdrawal is psychologically demanding. Rachel must get through 7–14 days of worsening headaches with the knowledge that improvement is coming — but on trust alone at that point. The GP's role is not just prescribing but providing a structured, supported withdrawal with a clear timeline, a named review date, accessible contact if severe, and validation that the plan is evidence-based and most patients succeed.

"I want to make a plan together — not just tell you what to do. Can you clear your diary for the first 2 weeks of withdrawal? If there's anything particularly important coming up at work that would make the timing impossible, we can plan around it. The goal is to give you the best chance of getting through this."
7H — Follow-up
T
Today — Stop OCP + Start Withdrawal + Start Prophylaxis

Stop combined OCP immediately; prescribe desogestrel 75mcg (Cerazette) OD or offer IUS/copper IUD. Stop paracetamol and codeine — plan simultaneous withdrawal. Prescribe naproxen 500mg BD × 14 days as bridge OR prednisolone 40mg × 5 days. Start amitriptyline 10mg nocte or propranolol 40mg BD. Warn Rachel that headaches will worsen for 7–14 days. Provide written information and Migraine Buddy app recommendation. Review in 2 weeks.

OCP STOPPED TODAYWithdrawal begins today — warn about 7–14 day worsening
2
2 Weeks — Withdrawal Review

Headache diary review: frequency reducing? Withdrawal period over? Analgesic use: still abstinent from codeine/paracetamol? Naproxen bridge completed? Any severe symptoms during withdrawal (if codeine dependence: formal dependence management). PHQ-9: mood during withdrawal phase. New contraception: how is the progestogen-only pill going? Any irregular bleeding? Prophylaxis side effects (amitriptyline: morning grogginess; propranolol: fatigue).

2-week withdrawal review — essential; do not skip
3
6–8 Weeks — Prophylaxis Assessment

Headache diary: migraine frequency now; is it episodic again? Prophylaxis response: amitriptyline or propranolol at therapeutic dose — any effect? Titrate if needed. Triptan: can now be introduced for acute attacks if headaches are episodic (MOH cycle broken). Sleep quality. Occupational function. PHQ-9. Review OCP decision — any change needed?

6–8 week prophylaxis review — titrate dose or switch if inadequate
4
6 Months — Prophylaxis Adequacy Assessment

Two adequate prophylactic trials? If two agents have failed at therapeutic dose for ≥3 months each: neurology referral (tertiary headache centre; CGRP antibody consideration). OCP: can she return to combined OCP if aura has fully resolved? No — migraine with aura + combined OCP remains UKMEC 4 regardless of current frequency. Review headache diary: ≥50% reduction in frequency = prophylaxis success. Consider 6-month trial of prophylaxis off (many patients can stop after sustained period of control).

6 months: failed two prophylactics → neurology referral for CGRP antibody assessment
7I — Monitoring

Headache monitoring essentials

Headache diary: count headache days/month and analgesic use days/month at every review — the most important monitoring tool; >10–15 analgesic days/month = MOH alert. OCP: once migraine with aura confirmed, combined OCP is UKMEC 4 permanently — do not restart regardless of current aura frequency. Propranolol: HR and BP at 4–6 weeks; asthma check. Amitriptyline: PHQ-9; morning grogginess; weight; ECG if >75mg. Topiramate: annual pregnancy test + contraception review (MHRA 2024); cognitive side effects; renal function + bicarbonate; eye check (glaucoma). GCA on prednisolone: ESR/CRP; BP; blood glucose; weight; DEXA; PPI; calcium + vitamin D; steroid card; sick day rules; annual eye check; rheumatology shared care. Cluster on verapamil: ECG (AV block); BP; HR; constipation. CGRP antibody (specialist): monthly injection or quarterly; injection site reactions; blood pressure; constipation (erenumab).

7J — Safety-netting

⚠ Three essential safety-net conversations in headache management

🔴 Emergency — thunderclap headache or neurological change
"If you ever get a headache that comes on suddenly like being hit on the head — reaching maximum severity within seconds — or if your current headaches change character completely, or if you develop weakness, numbness, speech problems, or a fever with a rash — those are different from your usual migraines and you should call 999 or go straight to A&E. Do not wait for a GP appointment."
SAH and meningitis present with headache and are immediately life-threatening. Patients with a known headache diagnosis (migraine, TTH) are at particular risk of attributing a new dangerous headache to their known condition. Specific characterisation of what makes a headache different from the usual ("sudden onset, reaching maximum severity in seconds") is essential and medico-legally protective.
💊 MOH withdrawal — the headache will get worse before it gets better
"In the next 7 to 14 days, your headaches are likely to get worse before they get better — that is the withdrawal process and it's expected. Please do not go back to the paracetamol or codeine. Use the naproxen as prescribed. If the withdrawal headaches are severe and you cannot function at all, call us — we can prescribe a short course of prednisolone to bridge the worst period. At days 10–14 you should start to notice improvement."
The most common reason for MOH withdrawal failure is that patients restart analgesics when the withdrawal headaches peak at days 3–7. Explicitly warning that the worsening is expected and does not mean the treatment is failing significantly improves success rates. Providing a rescue option (prednisolone) gives confidence to persist through the worst period.
🟠 Topiramate / OCP — pregnancy prevention
"I want to be very clear about the topiramate: it can cause serious harm to a developing baby if you became pregnant while taking it. The combined pill becomes less reliable when you take topiramate — the tablet we're using instead does not have this problem. Please do not stop your contraception while on topiramate. If you are planning a pregnancy at any point, tell me before you try to conceive — we'll switch to a different migraine preventive."
MHRA 2024 mandatory pregnancy prevention programme for topiramate. The interaction with OCP efficacy is a critical and commonly missed point. Specific counselling with documented informed consent is required and must be repeated at each annual review. Pregnancy on topiramate carries significant teratogenic risk — prevention requires specific patient education, not just assumption of compliance.
TodayOCP stopped; withdrawal starts; prophylaxis started; 2-week review booked
2 WeeksWithdrawal review; analgesic abstinence; prophylaxis side effects
6–8 WeeksProphylaxis response; headache diary; titrate or switch
🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills
Closing the consultation
"I want to bring this together. You have migraine with aura — the zigzag is the aura — and on top of that, the daily pain relief has created a second type of headache called medication overuse headache. These are connected and we need to address both."
"First: the combined pill. With the aura, the pill carries a significant stroke risk. I need to stop it today and give you a progestogen-only pill instead — Cerazette — which is just as effective and doesn't have that risk."
"Second: the paracetamol and codeine. I'm going to ask you to stop both of them completely. I know that's hard when you're in pain every day. But they are the main driver of the daily headaches. I'm giving you naproxen for 2 weeks as a bridge, and starting a preventive tablet — amitriptyline — at night. The next 10 days will be harder. I'll see you in 2 weeks."
"Third: I'm not going to give you stronger painkillers — I want to explain why. Stronger opioids would deepen the rebound cycle. The treatment is withdrawal, not escalation. I know that's not what you came in hoping for."
"I want to address the worry about something serious — a tumour. The pattern of your headaches, your mother having migraines, the visual aura, the 3-month history — this is not a brain tumour picture. I don't think we need a scan. But if the headaches change character — sudden onset, different from what you know — call 999 immediately."
Deductions
  • Not stopping the combined OCP — UKMEC 4 absolute contraindication; stroke risk; the most important safety intervention in this consultation
  • Not identifying or explaining MOH — the primary driver of Rachel's daily headaches; must be diagnosed and addressed with withdrawal plan
  • Prescribing stronger analgesics (codeine escalation, tramadol) — worsens MOH; serious clinical error
  • Not addressing the aura question — missed the most important clinical finding
  • Not warning about withdrawal worsening — Rachel will restart analgesics without this warning
Tasks — full criteria
  • SNOOP4 red flags excluded before treating as primary headache
  • Aura identified; OCP stopped; desogestrel prescribed (UKMEC 4)
  • MOH diagnosed; mechanism explained; withdrawal plan + bridge + prophylaxis
  • Topiramate: teratogenicity and contraception counselling if prescribed
  • Triptan prescribed for acute attacks (after MOH withdrawal)
  • Headache diary recommended; 2-week review booked
Relating to Others
  • Pain validated before withdrawal plan delivered
  • ICE all three; health anxiety addressed specifically
  • MOH paradox explained mechanistically, not dismissed
  • OCP addressed without blame; alternative offered
  • Stronger analgesic refusal explained with compassion not judgement
  • 2-week withdrawal support framed as partnership
🔴 Red
Stronger analgesic prescribed; OCP not stopped; aura not asked; MOH not identified; thunderclap not screened; GCA steroids delayed for ESR; topiramate in pregnancy without counselling
🟠 Amber
OCP discussed but not stopped; MOH identified but no withdrawal plan; red flags partially screened; prophylaxis prescribed without MOH addressed; ICE partial; withdrawal worsening not warned
🟢 Green
SNOOP4; aura → OCP stopped + desogestrel; MOH withdrawal + bridge + naproxen; amitriptyline/propranolol prophylaxis; no stronger analgesics; scan refusal explained; health anxiety addressed; ICE all three; withdrawal warning; 2-week review; closing question
Headache — SCA Consultation Scorecard
NICE CKS (2023) · SNOOP4 · Aura + OCP UKMEC 4 · MOH withdrawal · No stronger analgesics · GCA immediately · Topiramate MHRA
0/ 33 pts
🌐
Global Skills
Structure, language, responsiveness
0/7
Tasks
Clinical reasoning, diagnosis, management
0/15
🤝
Relating to Others
Communication, rapport, shared decision making
0/11
RAG Self-Assessment
🔴 Red
Stronger analgesic prescribed; OCP not stopped; aura not asked; MOH not identified; thunderclap not screened; GCA steroids delayed; topiramate without pregnancy counselling; no withdrawal warning
🟠 Amber
OCP not stopped despite aura; MOH identified but no withdrawal plan; no bridge; no withdrawal warning; prophylaxis without MOH addressed first; ICE partial; health anxiety not addressed
🟩 Green
SNOOP4; aura to OCP stopped + desogestrel; MOH withdrawal + naproxen bridge; amitriptyline or propranolol; stronger analgesic refused with mechanism; no scan with explanation; withdrawal warning; ICE all three; health anxiety addressed; 2-week review; closing question
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist to see your score and feedback
"I've been getting terrible headaches every day for 3 months. The paracetamol and codeine aren't working any more. I really need something stronger."
Who you are

Rachel Patel, 32, secondary school English teacher. Married with two children aged 6 and 9. You have had migraines on and off since age 18 — never formally diagnosed. Your mother has migraines. Three months ago your headaches escalated from once or twice monthly to almost daily following a very stressful start to term (new head of year role). You take paracetamol 1g + codeine 30mg on approximately 6 days out of 7 — the medication takes the edge off for 2-3 hours then the headache returns. You are on Microgynon 30 (combined OCP) for contraception, for 4 years. You use your phone heavily in the evenings and sleep 5-6 hours, irregularly. You drink approximately 10-12 units of alcohol weekly (2 glasses of wine most evenings).

Hidden details

Visual aura (critical — will NOT volunteer unless asked directly): About 20-30 minutes before most headaches, you see zigzag shimmering shapes in your vision. They move slowly across your visual field then disappear. You have had these for years and assumed they were "part of the headache." Only disclose if asked specifically: "Do you notice anything before the headache starts — like zigzag lines, flashing lights, or a blind spot in your vision?"

Brain tumour fear: Late-night Googling has made you worry about a brain tumour. You will not volunteer this unless asked what your biggest worry is. Responds very well to specific clinical explanation of why her headache pattern does not fit a tumour.

Codeine frequency: If asked carefully: "pretty much every day for 3 months — maybe 6 out of 7 days." Will admit this.

Headache details if asked
  • Bilateral frontal/temporal; throbbing; moderate-severe; worsened by movement; photophobia and noise sensitivity; nausea; 4-8 hours duration if untreated
  • Visual aura: zigzag shimmer, 20-30 minutes before headache (only if asked specifically)
  • SNOOP4: no sudden onset; no focal neurology; no fever; no positional change; not pregnant
  • No thunderclap headache; no weakness or speech problems
  • OCP: Microgynon 30, 4 years; no migraine discussion at prescribing; no BP check recently
Reactions
  • On aura question: "Oh — yes! I get these zigzag shimmering lines for about 20 minutes before it starts. Is that important?" Engages positively with aura explanation.
  • On OCP news: Initially surprised: "So the pill could cause a stroke? I've been on it 4 years..." Accepts Cerazette if offered with clear explanation.
  • On MOH explanation: Initial resistance: "But the codeine helps me get through the day..." Softens when the mechanism is explained with the brain thermostat analogy.
  • On no scan: "Are you sure? I've been reading about brain tumours..." Responds well to specific clinical reasoning. "So the zigzag and my mum having it — that confirms migraine?" Yes.
  • Challenge: "I've got 30 children every day — I cannot carry on like this. Can't you just give me something stronger?"
"I need something that actually works — I've got 30 children in front of me every day and I cannot carry on like this. Can you not just give me something stronger?"

Resolution: Rachel accepts the consultation if the GP: (1) asks about visual symptoms before the headache and identifies the aura; (2) stops the combined OCP and offers desogestrel; (3) identifies MOH and explains the rebound mechanism; (4) refuses stronger analgesics with compassion and clear rationale; (5) provides a structured withdrawal plan with bridge analgesic and prophylaxis; (6) warns explicitly that headaches will worsen for 7-14 days; (7) addresses the brain tumour worry specifically; (8) books a 2-week review. Rachel disengages if stronger analgesics are prescribed, OCP is not stopped, or she is sent home without a structured plan.

🏥
Clinic Quick Reference
Headache — Clinical Decision Framework
NICE CKS (2023) · SNOOP4 · SAH · GCA · MOH · OCP UKMEC 4 · Topiramate MHRA · Cluster O2
expand
🚨 1 — Triage Algorithm (SNOOP4)
Headache presentation → SNOOP4 screen (always first) → Emergency or primary headache → Characterise type → Treat
🔴 Emergency
  • Thunderclap (maximal in seconds): SAH → 999; CT head; LP if negative
  • Headache + fever + non-blanching rash: meningococcal → 999 + IM benzylpenicillin
  • GCA with visual loss → prednisolone 60mg NOW + ophthalmology
  • Focal neurology + headache → 999; CT head
  • Malignant hypertension (BP >180/120 + papilloedema) → 999
999 or immediate steroids (GCA)
🟠 Urgent
  • GCA without visual symptoms: prednisolone 40mg NOW; ESR+CRP; biopsy 2 weeks
  • Raised ICP features (papilloedema, progressive, morning): CT/MRI; neurology
  • New headache age ≥50: SNOOP4; ESR/CRP; exclude GCA
Same-day steroids (GCA); urgent imaging (raised ICP)
🟢 GP Management
  • Migraine + MOH: stop OCP if aura (UKMEC 4); MOH withdrawal; prophylaxis
  • TTH: lifestyle; amitriptyline if chronic
  • Cluster: O2 concentrator; SC sumatriptan; verapamil; neurology
Primary care; MOH withdrawal; prophylaxis
💊 2 — Key Treatment Rules
MOH and Migraine — What to Do
STOP combined OCP if migraine with aura (UKMEC 4) → desogestrel 75mcg or IUS
MOH withdrawal: stop ALL analgesics simultaneously; naproxen 500mg BD × 14 days as bridge; warn 7-14 day worsening
Prophylaxis (≥4 days/month): propranolol 40mg BD (no asthma) or amitriptyline 10mg nocte; 8-12 weeks to assess
Never Do
✗ Continue combined OCP with migraine with aura (stroke risk)
✗ Prescribe opioids for headache (deepens MOH)
✗ Delay GCA steroids for ESR or biopsy
✗ Topiramate without MHRA pregnancy prevention programme
✗ Cluster O2 via nasal cannula (must be NRB mask 12-15 L/min)
✗ Reassure thunderclap headache without CT head
✗ Propranolol in asthma or COPD (absolute contraindication)
Thunderclap = 999
Maximal in seconds → SAH → 999 → CT (98% sens within 6h) → LP if negative; never reassure without investigation
GCA: steroids NOW
Age ≥50 + temporal headache → prednisolone 40-60mg immediately; visual symptoms: 60mg; never wait for biopsy or ESR result
OCP + aura = UKMEC 4
Migraine with aura + combined OCP = absolute contraindication; stop OCP today; desogestrel or IUS; stroke risk; ask aura question at every OCP review
MOH thresholds
Simple analgesics >15 days/month OR triptans/opioids >10 days/month = MOH; withdrawal + bridge + prophylaxis; NOT escalation
Cluster O2: NRB 100%
12-15 L/min non-rebreather mask x 15-20 min; concentrator not cylinders; 70% response; oral analgesics are ineffective; SC sumatriptan 6mg alternative
Topiramate ⚠ MHRA
Teratogenic (MHRA 2024); mandatory contraception (implant/IUS; NOT OCP alone); annual review; "dopamax" cognitive side effects; NOT in pregnancy
Propranolol ✗ asthma
Absolutely contraindicated in asthma/COPD; first-line migraine prophylaxis; 8-12 weeks to assess; never stop abruptly; alternative: amitriptyline
Sumatriptan: not in aura
Take at headache onset NOT during aura; MOH threshold >10 days/month; CI: IHD, prior stroke/TIA, hemiplegic migraine, MAOIs, uncontrolled hypertension
⚠ 3 — Safety-Netting
🔴 Thunderclap or neurological change
"Sudden-onset headache reaching maximum in seconds; weakness; fever + rash; different from usual migraine → 999 immediately."
💊 MOH withdrawal warning
"Headaches will worsen for 7-14 days — expected; do NOT restart analgesics; call us if severe (prednisolone bridge available)."
🟠 Topiramate pregnancy
"Do not rely on the pill alone — use implant or IUS; if planning pregnancy tell me first; we will switch preventives."
Follow-up timeline
T
Today: OCP stopped; withdrawal starts; prophylaxis started; 2-week review booked
2w
2 weeks: Withdrawal complete? Analgesic abstinence? PHQ-9; side effects
8w
6-8 weeks: Prophylaxis response; titrate; triptan added if episodic
6m
6 months: Two failed prophylactics → neurology; CGRP antibody assessment
📌 Always ask aura question in migraine patients on OCP
🚨 Emergencies: Thunderclap → 999 + CT head · Meningococcal headache + fever + rash → 999 + IM benzylpenicillin · GCA + visual loss → prednisolone 60mg + ophthalmology same day · Malignant hypertension (BP >180/120 + papilloedema) → 999 · Pre-eclampsia headache → 999 + obstetrics
🛡 Safety rules: OCP + aura = UKMEC 4 — ask at EVERY OCP review · Topiramate: MHRA 2024 teratogenicity — implant or IUS mandatory; NOT OCP alone · Sumatriptan: NOT during aura; NOT in IHD or prior stroke · Propranolol: absolutely CI in asthma/COPD · Cluster O2: NRB mask 12-15 L/min concentrator (not cylinders; not nasal cannula) · GCA: steroids before biopsy — always
🎓
SCA Exam Quick Reference
Headache SCA — Ask Aura · Stop OCP · Explain MOH · No Stronger Analgesics · SNOOP4
Tasks · Relating to Others · Global Skills · RAG guide
expand
🕐 12-Minute Consultation Flow
0-2 min
SNOOP4 + open question
"Before I ask about the details — any headache that came on suddenly like being hit on the head? Any weakness, speech problems, fever? OK — tell me about the headaches."
Red flag screen first. Open question. Pain validated: "managing daily headaches while teaching is genuinely difficult."
TasksGlobal Skills
✗ Skipping SNOOP4 · ✗ Starting with closed questions
2-5 min
Aura question + analgesic count + ICE
"Do you notice anything before the headache — like zigzag lines, flashing lights, or a blind spot?" [Yes] "How often are you taking the codeine and paracetamol — how many days a week for how long?"
Aura = most important question. Analgesic frequency = MOH diagnosis. ICE: brain tumour fear; stronger medication expectation.
TasksRelating to Others
✗ Not asking aura · ✗ Not counting analgesic days
5-7 min
OCP stopped + MOH explained
"The zigzag is a migraine aura. With aura the combined pill carries a significant stroke risk — I need to stop it today." Then: "The daily codeine and paracetamol are the main thing driving the daily headaches — medication overuse headache."
TasksGlobal Skills
✗ Not stopping OCP · ✗ MOH not explained · ✗ Scan ordered
7-10 min
Refuse stronger analgesics + withdrawal plan
"Stronger opioids would deepen the rebound cycle. Stop the codeine and paracetamol completely — naproxen for 2 weeks as a bridge. The next 10 days will be harder — that is expected withdrawal. Amitriptyline every night to prevent attacks."
Validate pain before withdrawal message. Bridge (naproxen — not opioid or triptan). Prophylaxis alongside. Withdrawal warning mandatory.
TasksRelating to Others
✗ Prescribing stronger analgesic · ✗ No bridge · ✗ No withdrawal warning
10-12 min
Health anxiety + lifestyle + close
"The brain tumour worry — the pattern (aura, family history, bilateral, 3 months) is classic migraine; I don't need to scan you. Consistent sleep time is the most powerful free preventive. See you in 2 weeks. Anything else?"
Relating to OthersGlobal Skills
✗ Scan ordered · ✗ Health anxiety not addressed · ✗ No review booked
🔴🟠🟢 RAG — All 3 Domains
Tasks
🟢
SNOOP4; aura asked and identified; OCP stopped and desogestrel; MOH threshold counted; withdrawal + naproxen bridge; prophylaxis correctly selected; stronger analgesic refused with mechanism; scan not ordered with explanation; triptan after withdrawal; GCA steroids immediately if applicable; cluster O2 concentrator if applicable
🟠
SNOOP4 partial; aura asked but OCP not stopped; MOH identified but no withdrawal plan; no bridge; prophylaxis correct class but no titration plan; scan not ordered but health anxiety not addressed
🔴
Stronger analgesic prescribed; OCP not stopped; aura not asked; MOH not identified; GCA steroids delayed; thunderclap not screened; topiramate without pregnancy counselling
Relating to Others
🟢
Pain validated first; ICE all three; MOH paradox explained mechanistically; stronger analgesic refusal compassionate and reasoned; OCP not blamed; brain tumour fear addressed specifically; withdrawal framed as empowerment; occupational context acknowledged; 2-week support offered; closing question
🟠
Warm; MOH mentioned without full mechanism; stronger analgesic refused without explanation; health anxiety not addressed; OCP stopped without empathy; ICE partial
🔴
Stronger analgesic prescribed; pain dismissed; health anxiety ignored; OCP not stopped; no withdrawal plan; patient left without structured management
Global Skills
🟢
SNOOP4 first; aura question leads to OCP decision; MOH mechanism explained; scan refusal with specific clinical reasoning; withdrawal warning given; prophylaxis correctly selected (propranolol if no asthma; amitriptyline if depression or sleep); topiramate teratogenicity if prescribed; 2-week review booked
🟠
Adequate structure; SNOOP4 incomplete; aura missed; scan not ordered but no explanation; withdrawal plan vague
🔴
No red flag screen; aura not asked; OCP not addressed; stronger analgesic prescribed; no withdrawal plan; structural failures throughout
💬 Key Phrases
💡 Aura identification
"The zigzag shapes before the headache are a migraine aura — and they change what contraception is safe for you. The combined pill with aura carries a significant stroke risk. I need to change it today and give you an alternative that is just as effective."
🔉 MOH mechanism
"The daily pain relief is the main driver of the daily headaches. When you take it every day, your brain's pain-regulating system becomes overwhelmed and starts generating more pain between doses. The more you take, the more often the headaches come. Stopping the pain relief is the treatment that gives most people their lives back."
🎯 Stronger analgesic refusal
"I hear you — you're in real pain every day and the medication isn't working. The reason I won't give stronger painkillers is not because I don't believe you, but because stronger opioids would deepen the rebound cycle. Withdrawal is the treatment. I know that's not what you came hoping for — and I want to explain the plan."
🔍 Brain tumour fear
"I want to address the worry about something serious. The pattern of your headaches — years of the same thing, your mother has it, the visual zigzag, no weakness — is a very recognisable picture of migraine. I am not worried about a tumour. If I were, I would scan you today. If your headaches ever come on suddenly like being hit on the head, go straight to A&E."
📋 Withdrawal warning
"The next 7-14 days will be harder before they get better — that is expected withdrawal. Please do not restart the codeine or paracetamol. Use the naproxen I am prescribing. If the withdrawal is very severe, call us and I can prescribe a short steroid course. At day 10-14 you should start to notice improvement."
💚 OCP alternative
"The progestogen-only pill — Cerazette — is just as effective for contraception and does not carry the stroke risk. Some people get slightly irregular periods initially. I can prescribe it today and you start straight away with no break needed."
🚫 8 Danger Zones
Not asking about aura — the most important question→ Rachel will not volunteer her visual aura. It must be asked directly. Aura determines OCP decision (UKMEC 4), triptan restrictions (hemiplegic aura), and diagnostic certainty. Omitting this misses the most important clinical finding.
Prescribing stronger analgesics (opioid escalation)→ MOH is caused by analgesic overuse; opioids have the lowest MOH threshold (10 days/month). Escalating to tramadol or stronger codeine directly worsens MOH and is a serious clinical error. This is the most common SCA deduction in chronic headache presentations.
Continuing combined OCP with migraine with aura→ UKMEC Category 4 — absolute contraindication; significantly elevated ischaemic stroke risk. OCP must be stopped at this consultation. Desogestrel or IUS are effective alternatives. Failure to act on UKMEC 4 is a patient safety failure.
Not warning about MOH withdrawal worsening→ If Rachel is not warned that headaches will worsen for 7-14 days, she will restart analgesics when they peak at days 3-7 and interpret the worsening as treatment failure. The withdrawal warning is what enables persistence. Without it, over 50% of MOH withdrawal attempts fail.
Thunderclap headache dismissed or not screened→ SAH presents with thunderclap headache and is immediately life-threatening (25% mortality at first presentation). SNOOP4 screening must precede any primary headache characterisation. The sentinel headache (mild sudden headache days before major SAH) must not be dismissed.
GCA steroids delayed for ESR or biopsy→ Anterior ischaemic optic neuropathy from GCA can cause permanent bilateral visual loss within hours. Prednisolone must be started immediately on clinical diagnosis. ESR and temporal artery biopsy are arranged after treatment starts — never before.
Topiramate without MHRA pregnancy prevention counselling→ MHRA 2024: teratogenic. Mandatory pregnancy prevention programme. OCP alone insufficient (topiramate reduces OCP efficacy via CYP3A4). Implant or IUS required. Annual review with pregnancy test. Not counselling = medico-legally indefensible.
Propranolol without asthma check→ Propranolol absolutely contraindicated in asthma and COPD. Beta-blockade causes bronchospasm — potentially life-threatening. Always ask specifically about asthma before prescribing propranolol. If present: use amitriptyline instead.
💊 Drug Quick-Pick by Scenario
Acute migraine — first-line (NICE)
Aspirin 900mg + metoclopramide 10mg
Take at headache onset (NOT during aura); second-line: sumatriptan 50-100mg; restrict to max 10 days/month
Migraine prophylaxis — no asthma
Propranolol 40mg BD (titrate)
CI: asthma/COPD; 8-12 weeks to assess; do not stop abruptly; alternative: amitriptyline 10-75mg nocte
MOH withdrawal bridge
Naproxen 500mg BD x 14 days
OR prednisolone 40mg x 5 days; stop ALL analgesics simultaneously; 7-14 day worsening expected; warn patient
Cluster headache — acute
100% O2 NRB mask 12-15 L/min x 15-20 min
O2 concentrator (not cylinders); SC sumatriptan 6mg alternative; prophylaxis: verapamil SR + ECG; neurology
GCA — immediately
Prednisolone 40-60mg OD NOW
Visual symptoms: 60mg; never wait for ESR or biopsy; PPI + calcium/vitamin D + blood glucose from day 1
Migraine prophylaxis — depression or asthma
Amitriptyline 10mg nocte (titrate to 75mg)
Best when depression or poor sleep coexist; take at 22:00; 8-12 weeks to assess; QT monitoring if >75mg
Migraine with aura + OCP: STOP combined OCP (UKMEC 4) → desogestrel 75mcg or IUS · MOH: stop ALL analgesics simultaneously; bridge naproxen 500mg BD x 14 days; 7-14 day worsening expected — warn patient explicitly · Propranolol: ABSOLUTELY CI in asthma/COPD · Topiramate: MHRA 2024 teratogenicity — implant/IUS mandatory; NOT OCP alone; annual pregnancy test · Sumatriptan: take at HEADACHE onset (NOT during aura); MOH threshold: >10 days/month; CI: IHD, prior stroke/TIA, hemiplegic migraine, MAOIs · Cluster O2: MUST be NRB mask at 12-15 L/min (not nasal cannula; not low flow); concentrator for home · GCA: prednisolone before biopsy — always — irreversible blindness within hours if delayed · SAH: thunderclap = 999 = CT head — never reassure without investigation
Reviewed: July 2026 · citations verified against current NICE / UK guidance